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Abstract 
Stromal cells of the murine bone marrow receive increasing amounts of attention lately. They have 
been shown to support survival of hematopoietic stem cells as well as memory lymphocytes. 
Furthermore, their multipotency is the research foundation of contemporary regenerative therapies. 
Among these stromal properties their support of memory lymphocytes is of great importance when 
targeting the perseverance of autoimmune diseases. In the murine bone marrow, long-lived plasma 
cells reside in close proximity to a subset of VCAM-1+ stromal cells that secrete CXCL12. A similar 
pattern of interaction was observed for CD4+ memory T lymphocytes in contact with VCAM-1 
expressing stromal cells which provide them with survival signals such as Interleukin-7 constituting a 
subset within CXCL12+ stroma.  
Herein, a protocol was developed to quantitatively obtain VCAM-1+ and VCAM-1+ IL-7+/- stromal cells 
via enzymatic/mechanic digestion and cytoskeleton-inhibition. Ex vivo gene expression analysis was 
performed from sorted, pure cells with good recovery. Candidate genes/markers like CD1d, gas6 or 
ANXA2R were validated in (high-throughput) flow cytometry and histological analysis including 
subsequent semi-automated colocalization was performed. CD1d was found to be good surrogate 
marker for VCAM-1+PECAM-1- non-endothelial stroma while the population of 
CD200int/BP-1+/CD73+/CD105- stromal cells is greatly enriched in IL-7 producers which was equally true 
for the stromal transcription factor Prrx1. CD55, BP-1 and Cadherin-11 were found to be differentially 
expressed in differing IL-7 reporter mice haplotypes that mimic IL-7 abundance. For BP-1 and 
Cadherin-11, the resulting absence of mature lymphocytes could be ruled out as the reason. The 
reporter mice haplotypes revealed monoallelic expression features of IL-7. Regardless of haplotype, 
many hitherto lymphoid-associated markers such as PDC-TREM or CMKLR1 could be observed to be 
expressed on bulk stroma. Expression of gas6, ANXA2 or CD1d is not restricted to bone marrow stroma 
but was also observed in spleen albeit with less overlap and architectural differences. ANXA2 and its 
receptor ANXA2R were implicated in a new interaction between stroma and early B cell lineage in the 
bone marrow. 
All methodologies suggest that VCAM-1+ as well as IL-7+/- stromal cells are heterogeneous by marker 
expression yet don’t cluster extensively in flow cytometry co-stains. The functional relevance of the 
marker diversity described in this thesis remains to be tested but insinuates a broad repertoire for 
bone marrow stroma cells for new interaction pathways with lymphocyte subsets. Ultimately, this 
knowledge will hopefully feedback to clinical questions of autoimmunity for targeted treatment of 
stromal niches. 
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Zusammenfassung 
Stromazellen des murinen Knochenmarks sind in den letzten Jahren aus vielerlei Hinsicht in den Fokus 
der Forschung gerückt. Es konnte gezeigt werden, dass sie durch Bereitstellung von 
Überlebenssignalen essenziell für die Erhaltung hämatopoetischer Nischen sind – von der Stammzelle 
über Vorläuferzellen bis hin zu T-/B-Gedächtniszellen sowie Plasmazellen. Ein weiterer 
Forschungsansatz beruht auf deren Multipotenz, die man sich in regenerativen Therapien zunutze 
macht, aber die mangelhafte Klassifizierung der Ausgangszellen oft die Vergleichbarkeit von Studien 
erschwert. Besondere Relevanz haben die Stromazell-Nischen in der Ätiologie vieler 
Autoimmunerkrankungen. In Erkrankungen wie dem systemischen Lupus erythematosus (SLE) können 
maligne Plasmazellen, welche Antikörper gegen körpereigene Epitope sezernieren, Jahrzehnte 
überdauern und das eigene Gewebe nachhaltig schädigen. Während langlebige Plasmazellen zu 
CXCL12-positiven Knochenmarks-Stromazellen migrieren, konnte Interleukin-7 (IL-7) für T-Zellen als 
Überlebenssignal identifiziert werden, welches von etwa 50% der Stromazellen exprimiert wird. 
Gemeinsam ist allen Stromazellen die Expression des Oberflächenmarkers CD106/VCAM-1. 
Die Isolation von VCAM-1+ Stromazellen wurde mechanisch wie enzymatisch – u.a. durch Inhibition 
des Cytoskeletts via Latrunculin B – optimiert und erlaubte die quantitative und qualitative Gewinnung 
der Zellen in Einzelzellsuspensionen. Die ex vivo Heterogenität wurde via Genexpressionsstudien und 
ergründet und in situ in der Histologie verifiziert. Besonderes Interesse galt den IL-7+ Stromazellen zur 
Klärung der Fragestellungen, ob Gedächtnis-T-Zellnischen weiter unterteilt werden können oder alle 
Zellen um dieselbe Nische konkurrieren. 
Ein effizientes Protokoll erlaubte die qualitative wie quantitative Isolation von Stromazellen aus dem 
murinen Knochenmark mit anschließender ex vivo Microarray-Analyse. Die auf diese Weise ermittelten 
Kandidaten-Marker konnten auf Proteinebene via Histologie und (Hochdurchsatz-) 
Durchflusszytometrie validiert werden. Dazu gehören z-B. die Marker CD1d, gas6 or ANXA2R. CD1d 
wurde als guter Interimsmarker für VCAM-1+PECAM-1- nicht-endotheliale Stromazellen identifiziert 
werden, wohingegen die IL-7-Produzenten in der Population von CD200int/BP-1+/CD73+/CD105- 
Stromazellen angereichert ist. Gleiches gilt für den Transkriptionsfaktor Prrx1. CD55, BP-1 and 
Cadherin-11 zeigten eine Expressionsmuster in Abhängigkeit des verwendeten IL-7-Reportermaus-
Haplotyps, welcher die An-/Abwesenheit von IL-7 imitiert. Für BP-1 und Cadherin-11 konnte die 
Abwesenheit von reifen Lymphozyten als Ursache des Feedbacks ausgeschlossen werden. Die 
Haplotypen der Reportermaus legten auch eine monoallele Expression des IL-7 nahe. Viele Marker wie 
PDC-TREM oder CMKLR1 wurden unabhängig vom Haplotyp auf Stromazellen exprimiert. Die 
Expression von gas6, Annexin A2 (ANXA2) oder CD1d ist nicht auf das Knochenmarksstroma 
beschränkt, sondern wurde auch in der Milz beobachtet; dort jedoch mit geringerem Überlapp und 
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architektonischen Unterschieden. Darüber hinaus legen histologische Ergebnisse von ANXA2 und 
dessen Rezeptor ANXA2R eine mögliche Interaktion von Stroma- und B-Vorläuferzellen im 
Knochenmark nahe. 
Die Ergebnisse dieser Arbeit zeigen VCAM-1+ (IL-7+/-) Stromazellen als heterogene Population, wenn es 
nach der Vielzahl der möglichen exprimierten Marker geht.  Zwischen vielen dieser Marker gibt es aber 
wiederum auf Zelloberflächenebene einen großen Überlapp. Die funktionelle Relevanz dieser 
Oberflächenmarker-Diversität wird in weiteren Arbeiten zu klären sein, gibt aber den Stromazellen ein 
breites Repertoire vor, um Interaktionen mit Lymphozyten zu initiieren, modulieren und inhibieren. 
Abschließend bleibt zu hoffen, dass diese Erkenntnisse in die klinische Behandlung der Stroma-Nischen 
in Autoimmun-Fragestellungen einfließen. 
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1 Introduction 
1.1 Architecture of the murine long bones 
Bones are the scaffold of the vertebral organism and fulfill several functions within the body. While 
the most prominent is their supportive role for locomotion by offering anchoring points to tendons 
and muscles they also protect inner organs from traumatic events.  
In contrast to avian hollow bones, the mammalian counterparts contain bone marrow in their inner 
cavities which serve as the major site for generation of blood cells (explained in section 1.4) 
postnatally. Moreover, besides harboring a pool of progenitor blood cells the bone marrow recently 
was identified to be home to immune memory cells.  
The anatomy of a bone will be described by help of the murine femoral bone representative of all 
murine long bones. Generally, the bone is a mineralized cortex that is synthesized by osteoblasts in 
the bone marrow among other cell types. Moreover, there are two types of mineralized osseous tissue. 
While the dense cortical bone is making up the shaft of the bone it transitions into the so-called 
trabecular bone with a sponge-like appearance towards the joints (see Fig 1.1A). 
 
Fig. 1.1: Architecture and vascularization of the murine long bones A: Schematic depiction of long bone 
terminology and bone type distribution; B: Organization of the vasculature in the murine bone marrow of long 
bones as taken from Travlos et al.1 
Bone marrow is also connected to the blood circulation. Nutrient arteries enter the bone through the 
cortex (Fig. 1.1B). Similarly, periosterial arteries and veins were only recently identified to contribute 
substantially to blood exchange by crossing the cortex. In the bone marrow they form dense capillary 
networks termed the sinusoids that ultimately drain into the largest venous vessel that is the central 
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vein. Interestingly, bone marrow is not drained by the lymphatic system2 despite its pivotal role as the 
primary lymphoid organ in the generation, selection & maintenance of immature lymphocytes. 
Sinusoidal networks make up most of the space in bone marrow consisting of a luminal endothelial 
layer that is partially lined by adventitial reticular stromal cells3. The bone marrow parenchyma 
comprises a well-connected network of reticular stromal cells. These cells do not only act as connective 
tissue but also provide specialized microenvironments for cells of the early or late hematopoietic 
lineage as described below. Although murine bone marrow also contains adipocytes it is not divided 
into red and yellow bone marrow (containing mostly hematopoietic cells or adipocytes, respectively) 
as in the human equivalent3.  
Bone marrow is also densely innervated. While nerve fibers located in periarterial sheaths are thought 
to regulate vessel tone many nerve fibers terminate in the intersinusoidal areas. There, the fibers 
contact reticular stromal cells which were shown to carry β2- and β3-adrenergic receptors4, 5. 
Innervation together with gap-junctional communication of stromal cells regulates hematopoietic 
stem cell release by stress and in a circadian manner5, 6. 
1.2 Cellular composition of the bone marrow 
Cells of the bone marrow can be easily divided into the hematopoietic and the non-hematopoietic cell 
types. While the latter will be discussed further below the following paragraphs will deal with cells on 
the mesenchymal lineage that are non-hematopoietic and how they contribute individually to the 
various biological functions of bone marrow. 
1.2.1 Reticular stromal cells 
Reticular stromal cells make up the reticular scaffold of the bone marrow and are responsible for 
secretion of extracellular matrix (ECM) proteins. Much like fibroblasts, they show a spindle-shaped 
phenotype with long processes in culture. In addition, reticular stroma is connected via gap junctions7, 
8 and partly innervated by the sympathetic system as summarized earlier. 
Reticular stroma seems to be highly heterogeneous in terms of surface marker expression and 
differentiation potential. Due to its ability to differentiate into cells of the non-hematopoietic 
mesenchymal lineage (i.e. osteoblasts, adipocytes, chondroblasts) in vitro and in vivo9, the term 
“mesenchymal stem cell (MSC)” is sometimes used interchangeably for stromal subsets meeting 
certain requirements10. Multipotency was first observed in the 1970s by Friedenstein and coworkers11 
who used an adherence-based culture to characterize their clonogenicity and differentiation potential 
in vitro12. Even broader differentiation diversity could be shown in vitro including trans-differentiation 
capacity to ectodermal tissue (e.g. neurons13) in the presence of unphysiological media additives. 
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Hence, MSCs are increasingly considered for regenerative therapies. Nevertheless, their in situ lifestyle 
has not been fully elucidated, yet.  
Surface marker expression varies among reticular stromal cells as mentioned earlier. The lack of a 
stroma-specific marker contributes to the difficulties of studying their diversity. Several publications 
begin to shed light on the distribution of stromal subsets by assessing their enhanced proliferation 
in vitro as introduced by Friedenstein’s fibroblast colony-forming unit (CFU-F) assay12. 
Morikawa et al. reported a population of perivascular PDGFRα+/Sca-1+ stromal cells (PαS) that show 
increased CFU-F frequency in vitro and gave rise to perivascular cells and osteoblasts in a 
transplantation approach14. Using reporter mice expressing GFP under control of the promoter for the 
intermediate filament protein Nestin, another rare candidate MSC subset was defined15. Interestingly, 
Nestin is considered a neuronal or neuron-related protein16 contradicting the proposed mesenchymal 
phenotype of MSCs and might hint at a neural crest origin17. However, Nestin-GFP+ stromal cells were 
found in perivascular (periarteriolar for Nestin-GFPbright; perisinusoidal for Nestin-GFPdim) as well as 
endosteal areas of the bone marrow. When kept in culture, only CD45-Nestin+ cells were able to 
differentiate into osteoblasts, adipocytes and chondroblasts. Fate-mapping revealed that their in vivo-
potential was restricted to osteoblasts/osteocytes and chondrocytes. The expression of HSC support 
factors CXCL12, Interleukin-7, Angiopoietin-1, VCAM-1, stem cell factor (SCF) and Osteopontin hints at 
a highly versatile stromal subset15. Nestin as a defining stromal marker however is highly controversial 
in the field as summarized in a review by Xie recently18. 
A third study identified a pivotal role of Myxovirus resistance-1 promoter active (Mx1+) cells in stromal 
biology19. They could show that Mx1+ cells exhibit tri-lineage potential in vitro while only committing 
to the osteogenic lineage in vivo. Furthermore, Mx1+ cells could be serially transplanted and were 
highly motile in case of bone fracture to constantly replenish the osteoblast pool at the site of injury19.  
In contrast to the clonogenicity used in the studies before, a set of stromal cells was characterized 
regarding its high expression of CXCL12 / stromal derived factor 1 (SDF-1). Hence, those cells were 
termed CXCL12-abundant reticular (CAR) cells20, 21. They are scattered throughout the bone marrow20 
and associated with endothelial cells at the sinusoids, thus encompassing perivascular reticular cells21. 
CAR cells show bi-lineage potential differentiation behavior towards adipocytes and osteoblasts in 
culture and homogenously express the surface markers PDGFRα/β, VCAM-1, CD44 and 
Integrin αV (CD51)22. They contact several stage-specific cells of the hematopoietic lineage in the bone 
marrow such as HSCs, B cell progenitors and plasma cells20, 21 reflecting their vital role in B cell 
lymphopoiesis23, 24 in particular. In addition to the lymphoid lineages, myeloid cells similarly rely on 
stromal cues for their differentiation and survival. 
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In addition to CXCL12-expressing reticular stroma, another subset secreting Interleukin-7 (IL-7) was 
described20. IL-7 producers are found among PDGFRα+Sca-1+/- as well as VCAM-1+/- cells while only half 
of the VCAM-1+ stromal population expresses it25. Mostly overlapping with CAR cells26, IL-7+ stromal 
cells are also involved in early lymphopoiesis27, 28. Recent studies demonstrate their involvement in 
memory lymphocyte maintenance. 
Most recently, Leptin receptor (LepR) – previously thought to only be expressed on adipocytes – was 
proven to be a bona fide stroma marker as well as it is enriched for most CFU-F and marks most of the 
mesenchymal lineage while also being involved in HSC maintenance29, 30. 
While several stromal subsets have thus been described, the question arises whether they share 
similarities, overlap or even belong to the same subset. Considering the different degrees of 
multipotency of mentioned subsets it could be possible that LepR+ cells are the most stem-like cells, 
while bi-lineage potential PαS and osteogenic Mx1+ cells might represent more committed stromal 
phenotypes. Although CAR cells are more abundant than Nestin+ cells the subsets share similar 
characteristics15, 21, 22 indicating a certain overlap as well.  
1.2.2 Pericytes 
In vivo, many of the reticular stromal cells contact the endothelial layer of sinusoids and arterioles3, 31 
while their cell bodies can also be found distant from the vessels. Whether those perivascular stromal 
cells are identical or of different origin is still a matter of debate32, 33, 34. 
Some have argued for a common perivascular origin of all reticular stroma34, 35, 36 but depletion 
experiments37 with neural/glial antigen 2 (NG2) – a widely recognized, murine pericyte marker – 
showed that pericyte replenishment can even occur by endoderm-mesoderm transition (EMT) from 
endothelial cells casting into doubt such concepts in favor of more adaptive ancestors. 
Given that virtually all stromal cells express PDGFRs while endothelial as well as smooth muscle cells 
(characterized by α smooth muscle Actin) are a major source of PDGF as their ligand, stromal/pericyte 
proximity to vessels could merely reflect a survival benefit as PDGFRs are the mesenchymal 
maintenance receptors. 
In the context of the hematopoietic niche, it is by now widely accepted that ligand contributions to the 
HSC niche differ with regards to whether they are reticular, endosteal, perisinusoidal or periarteriolar38, 
39, 40, 41.  
1.2.3 Osteoblasts, osteocytes & osteoclasts 
Osteoblasts develop out of mesenchymal progenitor cells discussed above. They are short-lived and 
non-mitotic19. Their main function is to secrete the proteinaceous ECM that ultimately leads to bone 
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mass after mineralization42. Several transcription factors have been identified to be expressed during 
the progenitor-osteoblast-transition such as Runx2 or Osterix43, 44. Bone is constantly remodeled 
throughout the entire organism’s life. Thus, osteogenesis by osteoblasts is in strict balance with bone 
resorption by osteoclasts – macrophage descendants – and tightly regulated (e.g. by the WNT signaling 
pathway45).  
Besides modeling of the bone cortex osteoblasts have shown to be involved in HSC maintenance by 
expressing factors like Osteopontin, CXCL12, Angiopontin-1 or membrane-bound stem cell factor46. 
Consequently, depletion of osteoblasts by conditional models or disease results in mobilization of HSCs 
into the blood47, 48, 49. However, recent results question the necessity of osteoblasts for HSC support as 
hematopoiesis may alternatively occur in extramedullary sites47 and modulating the osteoblast pool 
size does not alter HSC numbers50, 51. 
Osteocytes are osteoblasts that have been encapsulated in the bone matrix. They are connected with 
each other via long processes – called canaliculi – for communication and nutrient exchange with the 
bone marrow52. 
1.2.4 Adipocytes 
Adipocytes are fat cells that are found scattered throughout the murine bone marrow in contrast to 
human white bone marrow as described earlier. They develop from mesenchymal progenitors such as 
CAR or Nestin+ cells that were shown to undergo adipogenesis in vivo22. Adipogenesis might be 
triggered by lack of mechanical signals53, 54 and is accompanied by expression of the adipogenic 
transcription factor PPARγ55. Adipocytes were shown to negatively regulate HSC maintenance 56. 
1.2.5 Endothelial cells 
Endothelial cells build up the inner lining of the vessels meandering the bone marrow and are covered 
by adventitial reticular stromal cells31. As such, they form a barrier to control molecule exchange and 
cell trafficking. Marrow endothelial cells express Laminin, von Willebrand factor (vWF) and Collagen 
IV3. Furthermore, they carry the surface proteins VCAM-1, E-Selectin and PECAM-1 that mediate 
leukocyte transmigration57. Similar to reticular stromal cells there is heterogeneity in expression of 
some markers. Sca-1 is found in arteriolar endothelium whereas it is not found on sinusoidal 
endothelial cells58. 
1.3 Bone marrow as the site of hematopoiesis 
In addition to the aforementioned cell types the bone marrow is the major site of hematopoiesis in 
mammals after birth59. Blood as a regenerative tissue undergoes a constant turnover of cells. Thus 
there is a need for long-lived stem cells that in hematopoiesis are called long-term hematopoietic stem 
cells (LT-HSC60). The HSCs reconstitute the diverse set of blood cells in a step-wise manner while 
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gradually losing multipotency. Short-term HSCs which originate from LT-HSCs differentiate into the 
common myeloid progenitor (CMP) – accounting for subsequent maturation of megakaryocytes, 
erythrocytes and myeloblasts – and the common lymphoid progenitor (CLP) whose offspring include 
natural killer, natural killer T (NKT), T-,  B- and innate lymphocytes (ILC) with varying responsibilities. 
Lineage commitment is tightly regulated by expression of several antagonistic transcription factors61. 
 
Fig. 1.3: Developmental pathway of the hematopoietic lineage Modified depiction of the developmental lineage 
from multipotent hematopoietic stem cell in the bone marrow over committed progenitors to mature cells inside 
and out of the bone marrow (Larsson & Karlsson, 2005, modified). LT/ST-HSC = long-/short-term hematopoietic 
stem cell; MPP = multipotent progenitors; CMP/CLP = common myeloid/lymphoid progenitor; NK(T) = natural 
killer (thymocyte); ILC = innate lymphoid cell 
HSCs are maintained in the bone marrow by reticular stroma in a specialized microenvironment. Over 
the last couple of years additional cell types including macrophages and the sinusoidal endothelium 
were found to be crucial in regulation of quiescence, self-renewal and differentiation of HSCs46. 
Furthermore, HSC cycling and release into the blood stream is under control of the sympathetic 
nervous system in a circadian rhythm4, 46.  
1.4 The mammalian immune system 
The mammalian immune system protects the organism from pathogens by discriminating molecules 
between self and non-self. Whereas germline-encoded canonical motifs are used at the level of innate 
immunity to identify potentially harmful microbiota it’s the plethora of antigen-specific receptors on 
immune cells of the adaptive immunity – i.e. T and B cells - that provide protection against antigens 
not yet encountered. The required receptor diversity is possible due to DNA recombination 
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mechanisms that each lead to genomic changes on the single-cell level during maturation of antigen-
specific immune cells in the lymphoid organs. 
1.4.1 Immunological memory 
Apart from its ability to recognize a vast number of antigens in an acute situation upon primary 
encounter, one particularly important function of the immune system is its enhanced response 
behavior when rechallenged with an already encountered antigen. As this feature is preserved over 
months in small vertebrates and decades in humans, the term “immunological memory” was coined. 
Whether it’s residual antigen that enables survival of antigen-specific cells or maintenance of reactive 
cells in the absence of antigen – as the strict definition of ‘memory’ requires – was a matter of debate. 
Meanwhile, the latter theory of antigen-independent maintenance was verified by switching the 
antigen-specificity of memory B lymphocytes62, memory T cells63 and long-lived plasma cells that 
produce antibodies regardless of antigenic instruction. In contrast, memory cells rather seem to 
depend on cytokine signals for survival64. Studies revealed that molecules of interest include IL-7 for 
CD4 memory cells65, both IL-7 and IL-15 for CD8 memory cells66, 67, 68, 69 and BAFF in combination with 
APRIL for memory B cell subsets70. Furthermore, other experiments identified CXCL12 (also known as 
SDF-1), ligands of CD44 and IL-6 to be able to promote survival at least in vitro71, 72. 
It hasn’t been until recent years that the underlying mechanisms for establishing immunological 
memory have been explored. When looking at acute immune responses it is observed that all 
antigen-specific lymphocyte subsets readily divide after receiving appropriate receptor stimuli in 
follicles of mostly spleen and lymph nodes which lead to a fast, clonal expansion in terms of cell 
numbers. This is followed by a contraction phase in which most of the clonal lymphocytes undergo 
apoptosis73. However, when tracking experiments were performed with CD4+ cells in a primary 
immune response to determine the localization during and after the expansion it could be seen that a 
small percentage of CD4+ cells relocate to the bone marrow while decreasing numbers were observed 
in the periphery74. 
1.4.2 Establishing the lymphocyte memory niche in the bone marrow 
In the bone marrow, CD4 memory T cells have been shown to contact VCAM-1 expressing stromal cells 
that also secrete IL-7 comprising about 1% of total bone marrow cells20 constituting a subset of 
VCAM-1+CXCL12+ plasma niche stromal cells (see Fig 1.4.2). Although the term niche originally stems 
from ecological theory where it’s defined as "a range of environmental conditions and resources 
needed for population persistence"75 it is meanwhile used to describe the spatially and temporally 
defined microenvironments needed for maintenance and survival of memory lymphocytes. 
Lenz, Daniel  1 Introduction 
8 
 
 
Fig. 1.4.2: Cellular and molecular composition of distinct BM stromal niches for memory lymphocyte subsets 
according to recent data Proposed composition of IL-7 dependent CD4+ TH memory cell (left) and long-lived 
plasma cell niche homing to CXCL12+ stromal subsets. Dashed line indicates uncertainty in how overlapping these 
sub-populations are. 
As memory CD4+ cells have been shown to be resting in terms of proliferation and migration the 
memory lymphocyte pool size is only maintained by the numbers of stromal cells rather than 
homeostatic proliferation. 
These findings bear clinical implications. Memory cells can also act pathophysiologically if specific for 
self-antigens. In this setting, the treatment of choice involves either immunosuppression or 
immunoablation - both putting the patient at high risk due to increased susceptibility for pathogens. 
However, memory cells - being resting both in terms of migration and proliferation – still fail to respond 
to the treatment methods targeting proliferating cells such as Cyclosporin A or total body irradiation76. 
1.4.3 Isolation of mesenchymal stromal cells 
It is desirable to target stromal cells involved in the maintenance and survival of memory lymphocyte 
subsets therapeutically to address the aforementioned disease-promoting abilities. Historically, this is 
a problem due to the accessibility of stroma itself. Adding to this comes the fact that studies often rely 
on adherence-cultured CFU-Fs12. The method takes advantage of the self-renewing capacity and multi-
lineage differentiation potential of mesenchymal stromal cells.   
This approach has flaws. While on the one hand non-adherent progenitors77 might be missed it has 
also been shown that surface marker expressions in CFU-Fs changes throughout passaging78, 79, 80. That 
might be due to transfer of stromal cells from a 3D to a 2D environment presumably lacking some of 
the in vivo triggers found in the extracellular matrix81. Additionally, the amount of marker 
combinations attributed to stromal cells hints at a high degree of heterogeneity with several subsets 
of stromal populations presumably involved in differing biological contexts as is the case for CXCL12 
and/or IL-7 expressing VCAM-1+ cells. Proposed marker sets include Sca-1/PDGFRα14, CD14682, 
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CD27183, 84 or Nestin15 amongst others described. Another dimension of confusion is added to the 
matter when trying to distinguish clearly between cell types of the bone marrow – especially across 
species. Markers as CD105/Endoglin are mainly expressed on endothelial cells85 but were also used for 
proper MSC isolation in human context86. PDGFRβ is a similar example as it was used for definition of 
both pericytes87 and MSCs88 in the murine model. 
1.5 Motivation 
In this thesis, the role and diversity of VCAM-1 and memory lymphocyte supporting IL-7 expressing 
stromal cells in particular stand to be analyzed. Until today, only a handful of signals were identified to 
be involved in the maintenance of memory lymphocytes such as CXCL12 or IL-7. Hence, one goal is the 
search for additional stroma-derived molecules that could interact with memory lymphocytes in the 
murine bone marrow niches or chemotactic signals keeping or guiding them there. Ultimately, finding 
surrogate surface markers that comprise several stromal subsets are another appealing goal as they 
would allow for future research on the particular function of these subsets especially in the case of 
autoimmune diseases where only cells of a certain function are ideally targeted. 
 
 
 
 
 
 
 
 
 
 
 
Lenz, Daniel  2 Materials & Methods 
10 
 
2 Materials & Methods 
2.1 Mice 
For general analyses in flow cytometry and for sorting of cells C57BL/6J mice aged between 7-12 weeks 
were used. Where indicated, IL-7 knock-in reporter mice 89 of 12-20 weeks were sacrificed. Both 
homozygous (IL7KI-/-) and heterozygous (IL7KI+/-) were used. Additionally, chimeric (C57BL/6J --> 
Ubiquitin:GFP or RFP) with fluorescent radioresistant cells or stroma reporter mice, 
i.e. B6.Cg-Tg(Prrx1-cre)1Cjt/J x Gt(ROSA)26Sortm1Hjf (PrxRFP), with fluorescent stromal cells were used 
for certain histological experiments (both Jackson Laboratory, Freiburg). These mice bred within the 
context of the dissertation of Sandra Zehentmeier 90 and provided by the workgroup of Anja Hauser 
(DRFZ). 
Where stated, mice deficient for Recombinase activating gene 1 (RAG1) from Jackson Laboratory 
(B6.129S7-Rag1tm1Mom/J) were used and further denoted as RagKO. 
2.1 Cell preparation 
Male C57BL/6J or chimeric mice aged between 7-12 weeks were sacrificed by cervical dislocation. The 
hind legs were prepared and the bones cleaned from muscle and tendon tissue and stored in PBS on 
ice.  
For flushing, the bones were then transferred to a petri dish filled with medium (RPMI 1640 
GlutaMAX™, Invitrogen, Carlsbad/USA) and the bones were cut close to the epiphyses. After that, a 
medium-filled syringe with appropriate needle sizes (i.e. 25G x 1’’ for femora, 22G x 1 ¼‘’ for tibiae; 
Sterican®, B. Braun Melsungen, Melsungen) was used to flush out the bone marrow strings as intact 
as possible. 
When crushing bones with pestle and mortar, 2 mL of PBS were put into a mortar pre-cooled on ice. 
The bones were crushed and brought to single-cell suspension by pipetting up and down several times. 
The suspension was then filtered (70 µm pore size, Nylon) into a 15 mL Falcon tube on ice. 
2.2 Enzymatic digestion 
The bone marrow flush-out and the empty bones (see section 2.1) were each transferred to one well 
of a 24-well culture plate each containing 400 µL of digestion buffer (RPMI 1640 GlutaMAX™ 
[Invitrogen], Penicillin/Streptomycin; 0.5 mg/mL Collagenase IV [Sigma-Aldrich, Taufkirchen]; 1 mg/mL 
DNase I [Sigma-Aldrich]; 0.25 mg/mL Dispase II [Roche, Grenzach-Wylen]; where indicated 2.5 µg/mL 
Cytochalasin D [Sigma-Aldrich] and  5 µg/mL Latrunculin B [Sigma-Aldrich] were added to the digestion 
buffer). After the marrow was cut into small pieces the plate was incubated at 37 °C and 5% CO2 for 15 
min. Subsequently, another 400 µL of digestion buffer were added to each well. Marrow samples were 
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gently resuspended with a pipette while the bones were flushed through with the digestion buffer. 
Again, the plate was incubated for 15 min at 37 °C and 5% CO2. Following that, 200 µL of PBS/BSA with 
10 mM EDTA were added to each well to stop digestion. Bone marrow samples were resuspended with 
a pipette and then filtered through a 70 µm Nylon mesh into 15 mL Falcon tubes to remove clumps. 
Additionally, the wells were washed with 1 mL of PBS/BSA/EDTA. The hollow bones were thoroughly 
flushed out with a syringe through a 22G needle. The resulting suspension was added to the 
corresponding tube.  
2.3 Flow cytometry and fluorescence-activated cell sorting (FACS™) 
Firstly, cell suspensions obtained from digestion were spun at 320 x g for 7 min at 4 °C. The supernatant 
was discarded and the pellet were resuspended in 300 µL of Fcy-receptor-Block (Clone 2.4G2, 10 µg/mL 
in PBS/BSA/EDTA). Following that, samples were incubated for 30 min on ice. When staining in 1.5 mL 
reaction tubes, an aliquot of ca. 2x107 cells was transferred from the initial sample. 
In the next step, the staining mix was added (see antibody list). Staining was performed for 20-30 min 
on ice in a darkened environment. After that, tubes were filled up to 1 mL or 10 mL according to a 
staining in a 1.5 mL reaction tube or a 15 mL Falcon tube, respectively. Samples were centrifuged for 
7 min at 4 °C, either at 320 x g or 973 x g according to the tubes used as aforementioned. 
The supernatants were discarded and pellets gently resuspended in 100-500 µL of PBS/BSA/EDTA and 
stored on ice. All samples were filtered before measuring (70 µm pore size, Nylon mesh). Additionally, 
compensation was carried out immediately before every analysis. This was done by measuring fresh 
cells only stained with antibody-dye-conjugates for each of the available channels with the 
corresponding dye of interest and software-side compensation between channels.  
When using DAPI for viability staining, it was added only before measuring at the given concentration. 
Cells were measured at 10,000 events per second at maximum. Data was analyzed by FlowJo software 
(v7.6.5, Tree Star Inc.). If not stated otherwise, gatings included single live cells and were also negative 
for lineage markers (see antibody list) or at least for RBCs (Ter119-).  
After staining and centrifugation, cell samples were resuspended in 500 µL PBS/BSA/EDTA and filtered 
(Pre-Separation filters, 30 µm, Miltenyi Biotec, Bergisch Gladbach) into a sorting tube. The tubes used 
for the initial cell suspension as well as for the sorted fractions were coated with RPMI + 10% FCS 3-4 
h before sort at room temperature. The tube for the total BM cell suspension was washed briefly with 
PBS/BSA/EDTA prior to adding the cell suspension whereas about 200 µL of medium were left in the 
fraction tubes (12x75 mm, 5 mL, PP, Sarstedt, Nümbrecht) to sort the cells into. Fluorescence-activated 
cell sorting was done at the Flow Cytometry Core Facility of the MPI/DRFZ at the Influx™ cell sorter 
(Becton Dickinson, Heidelberg). 
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Gatings were set to include 3 fractions, i.e. CD45-VCAM-1-PECAM-1-; CD45-VCAM-1+PECAM-1- and 
CD45-VCAM-1+PECAM-1+. In case of sorting IL7KI stroma, gatings were CD45-VCAM-1+GFP+PECAM-1-, 
CD45-VCAM-1+GFP-PECAM-1- and CD45-VCAM-1+GFP-PECAM-1+, respectively. Sorting speed did not 
exceed 15,000 events per second. Additionally, the hose system and the used buffers/ sheath fluid 
were cooled to 4 °C for sorting. Cells belonging to any of the mentioned fractions were then 
simultaneously sorted into the previously coated FACS™ tubes.  
After sorting, the cell counts and purity were determined on the flow cytometer (MACSQuant Analyzer, 
Miltenyi Biotec) with an aliquot of 30 µL. The suspensions were transferred into a 2 mL reaction tube 
and spun at 1520 x g for 5 min at 4 °C. Supernatants were discarded and the cells resuspended in lysis 
buffer of the appropriate RNA isolation kit (see 2.5). Lysed samples were stored at -80 °C until further 
RNA isolation. 
High-throughput surface marker screening via LEGENDScreen™ (Mouse Kit, BioLegend, Koblenz) was 
carried out as per manufacturer’s instructions. Bone marrow of long bones of three mice (aged 9-12 
weeks) per haplotype was pooled for the experiment. To account for comparison of IL7-GFP knock-in 
heterozygous vs. homozygous mice’ cells, only half the recommended volumes and cell numbers were 
used and the pre-titrated antibody solutions split into two. Samples were acquired sequentially on a 
flow cytometer (MACSQuant Analyzer 10, Miltenyi Biotec) with plate reader function and resuspended 
briefly before measurement. Depicted gates were set according to isotypes and fluorescence-minus-
one (FMO) controls included in the kit. 
2.4 RNA isolation & purity assessment 
RNA isolation was carried out by using the ZR RNA Miniprep (Zymo Research, Freiburg), the 
NucleoSpin® RNA II or XS kit (both Macherey-Nagel, Düren) mostly according to the manufacturers’ 
instructions. Changes to the protocol included heating up the water used for elution to 60 °C and 
reducing the elution volume in the recommended range. 
RNA concentrations were checked by measuring an aliquot of 1-2 µL at the NanoDrop (ND 1000, 
Thermo Scientific, Darmstadt) blanked with distilled water using the RNA-40 program. In addition, an 
aliquot of 2 µL was checked via electropherogram (BioAnalyzer 2100, Agilent Technologies, Santa 
Clara/USA) to assess RNA quality and integrity as seen by signal peaks specific for the 18S and 28S 
ribosomal RNA subunits. RNA samples were then stored at -80 °C. 
2.5 MicroArray analysis 
Total RNA isolates from 3 sorting experiments with a target population purity >80% were chosen to be 
used in MicroArray analysis. Fractions of interest were VCAM-1+PECAM-1- and VCAM-1+PECAM-1+. For 
analysis of IL7KI mice, sorted populations were VCAM-1+PECAM-1-GFP+, VCAM-1+PECAM-1-GFP- and 
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VCAM-1+PECAM-1+. Genome-wide analysis was done with the GeneChip Mouse Genome 430 2.0 Array 
from Affymetrix (Santa Clara/USA) according to manufacturer’s instructions.  
Chipset data was analyzed by applying the HPCDA algorithm as previously described 91, 92. 
2.6 Immunofluorescence 
2.6.1 Tissue preparation 
Fixation 
Bones obtained from freshly sacrificed mice were transferred to 15 mL Falcon tube containing about 
4 mL of 4% Paraformaldehyde (diluted from 20% PFA, Electron Microscopy Sciences, Hatfield/USA). 
Cells were allowed to be fixed for 4 h at 4 °C. To dehydrate the tissues the samples were transferred 
to a 10% sucrose solution. The sucrose content was increased 10%-step-wise every 24 h until 30% 
sucrose were reached. The bones stayed in 30% sucrose solution until the freezing procedure. 
Freezing 
For freezing, a steel plate was cooled to temperatures below 0 °C by placing it on dry ice in a container. 
While still at room temperature, embedding medium (SCEM, Section-Lab, Hiroshima/Japan) was 
added to specimen molds (Standard, Sakura Finetek, Netherlands). Subsequently, tissue samples were 
immersed in the embedding medium while avoiding air bubbles in the compound.  The specimen 
molds were then transferred onto the pre-cooled plate for freezing. The frozen blocks were wrapped 
in tin foil and stored at -80 °C until further use. 
Cutting 
Frozen bone tissue samples in embedding medium were cut at the microtome (HM 560 CryoStar 
Cryostat, Thermo Scientific) at -24 °C or at -19 °C for soft tissue. Section thickness was set to 6 µm. 
Slices were taped onto object slides for staining and stored at -80 °C according to the Kawamoto 
method93. 
2.6.2 Staining 
Object slides with tissue slices were thawed for 3 min in PBS. After drying the surrounding of the tissue, 
the area of interest was encircled with Dako Pen (Dako, Wiesentheid). In the next step, slides were 
blocked with PBS-T (PBS/0.1% Tween/5% FCS) for 30 min in a wet chamber. Staining mixes and 
corresponding isotype controls were prepared in 100 µL of PBS-T from which 50-75 µL were added 
according to the tissue. Incubation was performed in the wet chamber for 1 h at room temperature.  
Slides were washed three times with PBS/0.1% Tween in between staining steps. Ultimately, slides 
were incubated for 2 min in PBS and carefully dried afterwards. While avoiding bubble encapsulation, 
7 µL Fluorescent Mounting Medium (Dako) were pipetted onto the slides. The application of a cover 
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slip was followed by brief observation in light microscopy. The slides were then stored at 4 °C until 
measurement in fluorescence microscopy. 
2.6.3 Confocal Microscopy 
Fluorescence microscopy measurements were done on a LSM710 (Carl Zeiss, Jena) using the Zen 2011 
software. Averaging was set to Line 4, zoom to 1.0. The objective used was a Plan-Apochromat 20x 
with 0.8 numerical aperture. Z-stacks over 6 µm were acquired in a sequential manner with the pinhole 
set to 1 Airy Unit for each track – typically containing one channel. After merging z-layers to a 2D 
maximum intensity projection, contrast and brightness were adjusted in similar fashion for sample and 
isotype control slides. 
2.6.4 Cell quantification of stromal cells in histology 
The femora of 3 age-matched PrxRFP mice were prepared, fixed, embedded, cut & stained as 
described. 5 ROIs of equal size were arbitrarily set in the resulting tile scans. DAPI and RFP signals were 
subjected to thresholding by ImageJ with default presets. Subsequently, the cell count was determined 
via particle analysis (DAPI: default settings; Prx: size starting from 80 px² to only account for nucleated 
cell bodies). 
2.6.5 Semi-automated image analysis 
The semi-automated image analysis of confocal bone marrow pictures was done in collaboration with 
Ralf Köhler of the work group of Anja Hauser. In short, an ImageJ Java Macro calculates the respective 
overlap of two image fluorescence channels from Zeiss/ZEN *.lsm files. 
Firstly, the image threshold is defined by the signal to noise ratio, subsequently generating masks of 
unified signal intensities. The macro then counts for overlap pixel-wise. Visualization is done in pseudo-
colors of choice. The applet also provides an Euler diagram depicting overlapping and separate signal 
as part of the total pixels for better immediate depiction.  
Additionally, advanced image segmentation was provided by Wimasis, Munich with proprietary 
algorithms. 
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3 Results 
3.1 Obtaining viable stromal cells quantitatively via an optimized protocol 
3.1.1 Stromal cell isolation is sheer-force-sensitive and requires enzymatic digestion 
As is empirically proven, hematopoietic cell populations are effortlessly accessible in all of the 
commonly analyzed organs including spleen, lymph nodes and the bone marrow. To obtain a single 
cell suspension the tissues are disrupted mechanically via straining/crushing through a filter with 
defined pore size. Despite knowledge of potential losses due to these forces, the extent of loss was 
enigmatic as the total stromal content in the bone was unknown. 
To assess this question, histological slides of PrxRFP femora were imaged. Since Prrx1 is a mesenchymal 
lineage-restricted transcription factor, RFP expression is only induced in the stromal lineage and 
subsequent tissues/cells (osteoblasts, chondrocytes, pericytes etc.), allowing for an accurate estimate 
of stromal contribution to total nucleated bone marrow cells. By assessing different regions of the 
bone marrow, we could observe that reticular stroma was evenly distributed throughout the bone 
marrow with a consistent percentage of around 2% (see Fig. 3.1.1.1) of nucleated cells in the organ. 
Fig. 3.1.1.1: Quantification of the stromal cell content in murine bone marrow Femur of PrxRFP mice were 
longitudinally cut and stained for RFP and nuclei; ROIs were chosen at random, inlet refers to magnified ROI 1; 
scale: 500 µm; bottom left: representative quantification of total nucleated and nucleated PrxRFP+ cells in one 
mouse; bottom right: Average frequency of stromal PrxRFP+ cells among nucleated cells per ROI; n=3 ; graph 
depicts ROI values (left) or mean ± SEM (right) 
In terms of bone marrow stroma however, first experiments showed that for the proper isolation of 
stromal cells mechanical stress seems to have a negative impact on yield. Thus, several isolation 
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techniques were applied for comparison (see Fig. 3.1.1.2). This includes crushing the bones with 
mortar and pestle, flushing the bone with syringe and centrifugal flushing wherein the bone marrow 
is flushed out by using the centrifugal forces in a table-top centrifuge. 
 
Fig. 3.1.1.2: Effect of isolation method on stromal yield Representative Contour plots with 5% contour levels 
and outliers; gated on single, live, non-lineage cells; left: crushed with mortar and pestle in PBS/BSA/EDTA; center 
left: bones were flushed with a syringe and then transferred to digestion medium; center right: cut bones were 
placed in a pierced 0.5 mL reaction tube in a 1.5 mL reaction tube containing digestion buffer, tubes were spun 
shortly to flush out BM strings; right: quantification of dot plot conditions; n=3, mean ± SEM 
The lowest percentage was obtained with the crushed bones. Flushing the bones via centrifugation 
already increases the stromal percentage more than 4-fold compared to crushing. Nevertheless, the 
most prominent effect could be seen when flushing the bone with a syringe leading to an increase that 
is more than 10 times that of the crushed bones and still 3-fold more than similar flushing by 
centrifugation. 
As the stroma forms a three-dimensional network throughout the bone marrow it is necessary to 
extract the bone marrow as intact as possible in order to prevent the loss of stromal cells. Also, it 
remained unclear whether there were still considerable amounts of stromal cells left in the hollow 
bones. This problem was addressed by flushing the bone and then looking at stromal percentages in 
bone and/or flush after digestion (Fig. 3.1.1.3). Here, samples were prepared in different fashion. 
Firstly, a bone with removed metaphyses was incubated in digestion buffer. In a second approach, 
bones were flushed out as described before but instead digested separately from the empty bone. 
Stromal percentages were then assessed in each alone or both combined. To check for stromal cells 
that were still lining the inner surface of the bone empty bones were washed a second time with 
PBS/BSA/EDTA only. 
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Fig. 3.1.1.3: Distribution of stroma cells in the bone 
marrow and contribution to digestion yield BM samples 
of different origins cells were pre-gated according to 
scatter/singlets/viability/Ter119-; bones were incubated 
with cut ends only, flushed before digestion, incubated 
empty, or washed with PBS after second digestion 
incubation; percentages of CD45-VCAM-1+-cells of the 
parental populations are depicted in the plot. n=3; mean 
± SEM 
 
It can be seen that VCAM-1+ stromal cells are found in every sample obtained albeit in low percentages 
which is reflected by percentage and subsequently numbers among total bone marrow cells. 
Apparently, even empty bone still contained notable amounts of VCAM-1 positive stromal cells that 
were still present after flushing as can be seen in the PBS-flushed sample. In line with these results the 
protocol was changed to flushing the bone marrow, digesting flush and empty bone separately but 
mixing both samples to achieve higher stromal cell counts for further analysis. 
3.1.2 Stroma yield can be enhanced by Actin cytoskeleton-destabilizing agents 
Stromal cells adhere strongly to plastic surfaces and this property was used for enrichment of stromal 
cells from total BM cells. It couldn’t be ruled out that this would potentially decrease isolation 
outcome. As adherence is mainly depending on an intact actin cytoskeleton, drugs targeting F-Actin 
stability were chosen. Furthermore, attachment of cells to each other is prevented, thus potentially 
reducing doublets. 
Cytochalasin D is a mycotoxin isolated from Zygosporium mansonii and a potent inhibitor of actin 
polymerization by binding to its barbed ends and preventing further growth of the filament 94, 95. 
Latrunculin B, on the other hand, is a macrolide toxin derived from the red sea sponge 
Latrunculia magnifica. It disrupts the actin cytoskeleton by binding to the monomeric G-Actin in a 
1:1 stoichiometry, subsequently altering its subunit interface96 and reducing the amount of monomers 
available for polymerization94. 
In a pilot experiment not depicted the efficacy of both substances was tested in the designated 
concentration range on CD4+ memory lymphocytes in spleen while monitoring the F-Actin cytoskeleton 
via Phalloidin staining. It could be confirmed that both reagents severely affected the structure of F-
Actin. 
In the next step, it remained to be evaluated how each of the inhibitors individually contributes to the 
effect observed earlier and whether one of them might already be sufficient to achieve a higher yield 
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in stroma isolation (Fig 3.1.2). For this, no inhibitors, one only or both combined were added to the 
digestion buffer and incubated with the cells as described earlier. Any subsequent buffers were free 
of inhibitors. 
 
Fig. 3.1.2.: Differential, dose-dependent 
impact of Cytochalasin D and Latrunculin B 
on stromal preparation outcome A: 
Representative contour plots of bones 
digested ± Cytochalasin D/ Latrunculin B, 
each alone or both combined (at 
2.5 or 5 µg/mL, respectively). B: 
Quantification of CD45-VCAM-1+PECAM-1- 
cells in conditions ± LatB, n=9, data are mean 
± SEM; C: Viability in samples of conditions in 
B, data are mean ± SEM;  D: Representative 
contour plots with 5% level and outliers; 
different concentrations of Cytochalasin D 
and Latrunculin B were applied to digestion 
buffers of cells (low: 0.25 µg/mL and 0.5 
µg/mL; intermediate: 2.5 µg/mL and 5 
µg/mL; high: 25 µg/mL and 50 µg/mL, 
respectively); cells were pre-gated for single, 
live Lin-Ter119- cells; E: Quantification for 
observations in D, mean ± SEM 
 
The control digestion without inhibitors reflects the yield variation of the isolation protocol. 
Nevertheless, a positive impact on digestion outcome can be observed with the cytoskeleton-
destabilizing agents. Interestingly, Latrunculin B alone yields a percentage of VCAM-1+ stroma cells that 
is comparable to both of the inhibitors added to digestion medium. However, Cytochalasin D also 
increases the stromal yield albeit in a lower manner. Importantly, survival of cells was not impaired in 
the absence of cytoskeleton inhibitors (Fig 3.1.2B). While according to the percentages obtained 
Latrunculin B would be sufficient for future isolation both inhibitors were chosen due to their differing 
modes of action on the cytoskeleton and published synergistic effects97. 
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Reviews on the working principles of Cytochalasin D and Latrunculin B found them to exert a dose-
dependent effect on cells. To find the optimal balance between increasing the stromal yield and risking 
loss of stroma due to the cytotoxic effect of both substances a titration was performed (Fig. 3.1.2D-E). 
Here, both toxins were added to the digestion buffer in a concentration range between 0.25-25 µg/mL 
(Cytochalasin D) and 0.5-50 µg/mL (Latrunculin B), respectively. 
Although a yield increase can be seen in comparison from using 10-fold less inhibitor (low) than usually 
(intermediate), the difference between intermediate and 10-fold higher concentrations is only 
marginal. In addition, a slight decrease in viable cells could be observed in samples with high inhibitor 
concentrations proving the undesirable cytotoxic effects of Cytochalasin D and Latrunculin B (data not 
shown). In accordance with these data, an intermediate concentration of Cytochalasin D and 
Latrunculin B (2.5 or 5 µg/mL, respectively) was used for further isolations.  
3.1.3 Pure stroma populations can be obtained via FACS™ with good recovery 
The ultimate goal of the study is to characterize the stroma cells in terms of surface marker expression 
and their diversity. This is due to the lack of a clear stromal surface marker by which stromal cells could 
be stained. Additionally, it is of importance to analyze cytokine and chemokine expression of VCAM-1+ 
stromal cells to understand their interaction with memory lymphocytes a little better.  
To get pure populations of VCAM-1+ stromal cells BM suspensions were sorted according to surface 
marker expression. The staining involved the same markers previously used for assessment of the 
enrichment with the cytoskeleton inhibitors. After gating out dead cells, doublets as well as Lin+ cells 
three populations were sorted at the FACS™ machine. This included the stromal (CD45-
VCAM-1+PECAM-1-) and endothelial fraction (CD45-VCAM-1+PECAM-1+) as well as 
CD45-VCAM-1-PECAM-1- cells. Purity was assessed on a flow-cytometer (see Fig. 3.1.3). 
Despite only few sorted cells due to the generally low percentage of the cells of interest high purity 
could be achieved for all fractions as seen in Fig. 3.4.1. It must be noted, however, that about 15% of 
sorted VCAM-1+PECAM-1+ cells are PECAM-1- most likely due to cells on the y-axis that could implicate 
clotting of the tubing system or a compensation issue. Latter could be excluded after checking the 
settings. 
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Fig. 3.1.3: Flow cytometric analysis of sorted murine BMSCs Aliquots from the fractions sorted at BD Influx were 
measured at the MACSQuant Analyzer and depicted as contour plots with 5% levels and outliers as modified in 
FlowJo software; left column: gated on Scatter/Singlets/Lineage-Ter119-Gr-1-; center column: gated on 
Scatter/Singlets/Lineage-Ter119-Gr-1-/CD45-VCAM-1-/+, respectively; right: quantification for purity (top) and 
total recovery from beginning of the isolation (bottom). Mean ± SEM 
To rule out that the viability staining was washed out of dead cells additional dye was added before 
checking the purity. The experiment showed that the majority of the cells survive the long incubation 
step in the tube at the sorter (data not shown). 
 
Stromal and endothelial cells that were sorted at the Influx according to the aforementioned gating 
strategy were afterwards lysed for RNA isolation in those cases when a sufficient purity was obtained. 
RNA content was measured via NanoDrop (Tab. S1). To assess the quality and integrity of the prepared 
RNA samples a small aliquot was run in an electropherogram (BioAnalyzer 2100, Agilent Technologies). 
The overall integrity was determined as RNA integrity number or RIN98 (see Tab. S1).  
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3.1.4 Bulk stromal cells express a broad set of genes reminiscent of the mesenchymal lineage but 
enriched for cell adherence pathways 
Cell populations sorted by FACS™ were lysed for RNA and subsequently checked for their gene 
expression in microarrays. Data is depicted in Tab. S2 and derived from 3 different experiments for 
PECAM-1+ and PECAM-1- each. 
The excerpt of differentially expressed genes in Tab. S2 shows only few of the several thousand genes 
that the HPCDA score ranked algorithm identified to be significant. Firstly, proteins that have been 
published to be expressed in stroma or endothelium could be shown here on the RNA level as well (see 
Fig. 3.1.4). That is true for CXCL12 as one of the key molecules in the plasma niche but also for PDGFRβ 
– a receptor that has been described to be involved in angiogenesis but also as a pericyte-defining 
surface marker in bone marrow (see Fig. 3.1.4). Other molecules such as Kit ligand were shown to be 
present on stroma cells as c-Kit+ HSC are supported by Kit ligand MSCs99. For endothelium in contrast, 
genes like Endoglyx-1100 or E-Selectin101 were found to be highly expressed in PECAM-1+ cell 
transcriptomes. Both are linked to endothelium almost exclusively.  
 
 
Fig. 3.1.4: Trends in gene expression and cell type 
distribution of genes highly expressed in stromal 
cells Fold change (FC) of representative endothelial 
(negative FC) and stromal (positive FC) genes that 
were differentially expressed in the micro arrays; 
data depicts mean of n=3 
 
However, the transcriptomes did not only consist of genes that have been linked to reticular stromal 
cells or endothelium. Several markers of the mesenchymal lineage were present in both 
transcriptomes (Fig. 3.1.4). For example, gene expression in stromal cells is increased for genes related 
to adipogenesis (Adiponectin, Esm1102, FABP4, ACAM103, 104) or osteogenesis (Osteoglycin, Bone 
sialoprotein, Runx2). 
To get a broader idea which physiological pathway the differentially expressed genes are involved in, 
a gene-set enrichment assay (Cytoscape BiNGO) was performed (Tab 3.1.4). 
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Tab. 3.1.4: Gene-set enrichment analysis in GO category pathways among differentially expressed genes of 
stromal and endothelial cells Gene sets that were enriched in the micro arrays according to Cytoscape BiNGO; 
x: number of genes from GO category enriched; n: total number of reference genes in GO category 
p-value x n Description 
1.58E-08 77 200 Focal adhesion 
4.00E-07 27 50 Ribosome, eukaryotes 
3.33E-05 72 218 Proteoglycans in cancer 
8.81E-05 98 325 PI3K-Akt signaling pathway 
1.28E-04 95 316 Pathways in cancer 
3.92E-04 63 199 Endocytosis 
7.72E-04 31 84 ECM-receptor interaction 
1.24E-03 29 79 Gap junction 
1.30E-03 9 15 Glycosaminoglycan biosynthesis - keratan sulfate 
1.33E-03 32 90 Ribosome 
1.51E-03 31 87 GnRH signaling pathway 
2.69E-03 42 131 Axon guidance 
3.51E-03 18 45 Sphingolipid metabolism 
4.87E-03 60 206 Regulation of actin cytoskeleton 
6.11E-03 48 160 Transcriptional misregulation in cancer 
8.70E-03 19 52 Glutathione metabolism 
8.80E-03 17 45 Notch signaling pathway 
1.24E-02 24 72 Adherens junction 
1.44E-02 28 88 Prostate cancer 
1.45E-02 20 58 Long-term depression 
1.63E-02 22 66 VEGF signaling pathway 
1.85E-02 38 129 Tight junction 
2.05E-02 67 249 MAPK signaling pathway 
2.16E-02 4 6 Glycosaminoglycan biosynthesis, chondroitin sulfate backbone 
It is apparent at first sight that many of the categories enriched either are involved cell-substrate (focal 
adhesion, ECM-receptor interaction, Regulation of Actin cytoskeleton) or cell-cell adhesion 
(gap junction, tight junction, adherens junction). Another recurring theme is cancer physiology 
(Proteoglycans, Pathways, Transcriptional misregulation in cancer). Some general signaling pathways 
are enriched (PI3K/Akt, Notch, VEGF, MAPK) as well. Stromal very active contribution to surrounding 
ECM is represented by Keratan and Chondroitin sulfate GAG synthesis. 
Surprisingly, some rather neuron-affiliated processes (GnRH signaling, long-term depression and axon 
guidance) are also enriched. 
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3.1.5 Identification of possible memory niche interactions by complementary transcriptomics 
As outlined briefly in the introduction, the concept of stromal niches is thought to be a recurring theme 
throughout the developmental stages of a hematopoietic cell. 
Our group had already generated transcriptomes of several memory lymphocytes, including CD4, CD8, 
B and long-lived plasma cells. For the first time, we now had ex vivo transcriptomes of their elusive 
stromal binding partners of the corresponding niches at hand. We hypothesized that since survival and 
adherence factors must be based on the principle of receptor-ligand interactions, there should be a 
way to devise an algorithm that could scan each transcriptome for possible interactions between the 
cell populations (see scheme in Fig. 3.1.5A). Contrary to the depiction in the figure, those interactions 
do not necessarily have to be surface-surface but could well include secreted factors from one side. To 
make the visual presentation of these binding partners more appealing, the results were embedded 
into maps available via the Kyoto Encyclopedia of Genes and Genomes (KEGG). One such example is 
depicted in Fig. 3.1.5B for the complementary transcriptomics of bulk stromal cells and long-lived 
plasma cells, both generated in our group.  
 
Fig 3.1.5 Ligand-receptor pairing by 
complementary transcriptome analysis (A) 
Scheme depicting the general workflow in 
complementary transcriptomics for ligand 
receptor pairing. In short, transcriptomes are 
generated from purely sorted stroma or (memory) 
lymphocytes preparations. The program is then 
comparing present genes105 with curated 
databases of known trans-interactions (e.g. from 
KEGG) to predict possible ones (black frame) (B) 
Exemplary readout for the comparison of CD45-
VCAM-1+PECAM-1- stroma with long-lived plasma 
cells. All boxes are ligands/receptors in the KEGG 
Cytokine/Chemokine pathway [hsa04060] (left). A 
blue box indicates the presence of a given gene in 
stroma whereas red box shows presence in 
plasma cells, as outlined for the known interaction 
of CXCL12/CXCR4 (right). 
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In line with contemporary literature, one interaction that can be observed from both transcriptomes 
is that of stroma-derived CXCL12/SDF-1 and its cognate receptor CXCR4 on long-lived plasma cells (Fig 
3.1.5B, inlet and magnified on bottom right). In the curated list of known cytokine/chemokine and 
corresponding receptors, we have each molecule split into two boxes to show whether the transcript 
was present or absent in either transcriptome (stroma: blue, plasma cells: red). 
3.2 Assessing the heterogeneity of murine bone marrow IL-7+ stroma cells 
Having established a digestion protocol for quantitative isolation enabled us to look at the majority of 
the stroma cells without extensive cell death during the preparation. Also, analyzing the stromal gene 
expression despite low cell numbers from FAC-sorted cells seemed feasible as the transcriptomes in 
Fig. 3.1.5 showed. However, as these compared stromal to endothelial cells as characterized by their 
differing germ layer origins, the differentially expressed genes were not immediately informative for 
the stromal niche composition and heterogeneity. Naturally, we wanted to explore the heterogeneity 
within a stromal subset whose function was already established. IL-7 is known to play a crucial role in 
the survival and maintenance in memory T lymphocytes and early B cell lineage progression. 
3.2.1 IL-7+ stromal cells have significantly higher Prrx1 levels than IL-7- counterparts 
As intracellular staining of IL-7 didn’t prove feasible due to low steady state concentrations and 
because it interferes with sorting/RNA preparations, heterozygous reporter mice in which GFP has 
been knocked into the Il7 gene (Fig. 3.2.1A) were used instead. In the heterozygous genotype, the 
remaining functional IL-7 seemed to be sufficient to drive T and B cell lymphopoiesis as their numbers 
were not drastically altered (data not shown). Hence, it’s assumed to mimic the wild-type accordingly 
without influencing the niches in the bone marrow. 
Mice have been sacrificed as previously described for bulk stromal transcriptomes and pure cells 
sorted from FACS™ (Fig. 3.2.1B-C). The comparison of differentially expressed genes between 
GFP+PECAM-1- and GFP-PECAM-1- samples shows that they cluster according to phenotype and differ 
significantly (Fig. 3.2.1D). 
The top list of differentially expressed genes according to the ranking by HPCDA score first of all 
revealed that these transcriptomes are vastly more similar to one another as seen by their relatively 
lower HPCDA scores in contrast to the bulk stroma vs. endothelial cell analysis (Tab. S3). The fact 
however that many of the top genes are supposedly myeloid genes (Ly6C, NGP, Lyz1, MPO) argues for 
considerable contamination by these cells that didn’t show up in the sorting controls. We were 
therefore critical of the data and didn’t follow it up for candidate markers. 
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Another reason for concern was that despite sorting for GFP+ and GFP- cells, Il7 transcript could be 
determined independently by two Affymetrix probes in the GFP- sorted cells (Fig. 3.2.1E).  
 
 
 
 
 
Fig. 3.2.1: Gene expression analysis of Interleukin-7 reporter GFP stromal cells (A) Schematic depiction of the 
IL7KI design used with boxes being exons/cDNAs and ‘B’ depicting BamHI cutting sites. (B) Cells were isolated 
from heterozygous IL7KI mice and analyzed for their GFP fluorescence in the VCAM-1+ population; gated on live, 
Ter119-Lineage-CD45-VCAM-1+ singlets. (C) Purity (left) and total recovery (right) after cell isolation and sort; (D) 
Heatmap comparing the gene expression of GFP+PECAM- with GFP-PECAM- sorted cells. Data from 3 independent 
arrays from 4 mice. zScore of log2 expression values in the range from -2.1 (green) to 2.1 (red). Genes selected 
are limma p < 0.05 and -1.3 < fold change <1.3; (E) Overview of Il7 and Prrx1 probe mean signals between 
GFP+PECAM-1- and GFP-PECAM-1- sorted cells 
 
However, among the controversial list of top genes we could also find the stromal master transcription 
factor Prrx1 that is readily used in stromal reporter mice. Surprisingly, it is expressed twice as high in 
the GFP+ fraction of stromal cells than it is in the GFP- cells (Fig. 3.2.1E). 
3.2.2 Ex vivo co-expression of immune regulatory hematopoietic surface markers on stromal cells 
As gene expression analysis via micro arrays is always a population-level approach to assess diversity, 
we were wondering whether it was possible to miss small stromal subsets due to unproportional bias 
of larger ones in the gene expression. 
Therefore, an unbiased surface marker screening approach based on flow cytometry was chosen 
(LEGENDScreen™, Mouse Kit, BioLegend). This managed to combine a population-spanning with a 
single-cell level approach. To get further insight into how the availability of IL-7 might also determine 
stromal marker expression via feedback loops, the analysis was done on both IL7KI heterozygous and 
homozygous mice. Given the kit’s bias towards hematopoietic cells as mostly canonical “cluster of 
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differentiation (CD)” antibodies are included, still a considerable amount of these CDs seemed to be 
expressed by bulk stromal cells and GFP+ cells. 
Of those markers expressed, different general expression modes could be observed. While some 
markers only showed expression among GFP- stromal cells (e.g. CD55, Tim-1), others could be found 
on both GFP+ and GFP- stromal cells such as CD1d or CD63. There was hardly a scenario where a marker 
was exclusively expressed by the GFP+ compartment although general enrichment in this population 
could be seen (see CD73 intermediates or CD54). Expression is rarely confined to the stromal 
population but can be found in same or differing levels on endothelial cells (blue populations) or CD45+ 
hematopoietic cells that served as an internal reference population for gating (data not shown). 
Interestingly, stromal marker and/or GFP expression appear mutually exclusive for several of the 
tested surface markers (CD160, APRIL, PD-1, PDC-TREM).  
Of note, it is rarely the case that markers are vastly differentially expressed between stroma and 
endothelial cells (CD140a/b, CD105, CD54) which makes using any of the tested markers as an elusive 
surrogate marker in the mouse problematic.  
Apart from the persistent observation that there are haplotype-dependent expression level 
differences of GFP (further noted in section 3.2.8), the lack of a functional wild-type IL-7 allele didn’t 
seem to impact vastly on surface marker phenotype.  Minimally altered expression patterns can be 
found for CD73, PD-1 among others. CD55/DAF stands out in the homozygous scenario as a 
considerable GFP+ stromal population can be observed in that haplotype. 
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Fig. 3.2.2.1: Differential surface marker expression on CD45-VCAM-1+ PECAM-1+/-GFP+/- BMSCs between IL7KI 
haplotypes Representative contour plots of marker vs GFP between IL7KI heterozygous (+/-) or homozygous 
(+/+) mice (n=3); CD45-VCAM-1+ cells either being PECAM-1 positive (blue) or negative (red); gates were set 
according to isotype controls and/or FMO; samples were gated for viable, non-lineage (at least Ter119-) singlets 
Upon verifying some of the markers from the screening in a multiplexed approach in a follow-up flow 
cytometry experiment using the same hybridoma clones on wild-type C57Bl/6 mice we could confirm 
the very limited stromal heterogeneity on a per-cell level, at least for the clones/markers tested 
(Fig. 3.2.2.2).  
Fig. 3.2.2.2: Considerable population overlap in surface marker expression of stroma-related surface molecules 
on CD45-VCAM-1+ BMSCs in multiplexing flow-cytometric analysis Dotplots of CD45-VCAM-1+ cells from C57Bl/6 
mice with top and side labels corresponding to y- and x-axis, respectively; samples were gated for viable, non-
lineage singlets according to FMO control 
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It is pretty apparent when looking at CD200 or CD1d counterstains with the other markers, only one 
pronounced population can be determined – the exception for both being CD73 and CD105 where a 
clear separation into two subpopulations can be seen. A much wider distribution of marker 
combinations can be seen in the case of BST2 vs CD73/CD105, although cells don’t show a bimodal 
expression pattern in either scenario. That recapitulates the staining pattern of CD73 vs GFP in the 
prior screening experiment. 
3.2.3 CD1d as surrogate marker for VCAM-1+PECAM-1- stromal cells  
A potential goal of this screening approach was not only to find substantial sub-populations among 
stromal cells but also to identify surrogate markers for known population. One problem with our 
established staining protocol has always been the reliance on VCAM-1 to identify stromal/endothelial 
cells and additionally PECAM-1 to exclude endothelial cells from the gating. While confirming the 
expression of CD1d on stromal cells, it could also be shown that its expression is considerably higher 
on the majority of stromal cells (Fig. 3.2.3.1, upper right, Q1). A different gating on CD45-CD1dhi cells 
revealed to contain the majority of the VCAM-1+PECAM-1- stromal compartment with only negligible 
amounts of PECAM-1+ or double-negative cells to be included in line with the initial screening results. 
 
Fig. 3.2.3.1: CD1d is a surrogate 
marker for VCAM-1+PECAM-1- cells 
First row: Dotplots of bulk VCAM-1+ 
CD45- stroma that is largely CD1d+; 2nd 
row:  CD45-CD1d+ cell do include the 
majority of VCAM-1+ cells while barely 
staining for PECAM-1); samples were 
gated for viable, non-lineage singlets 
according to FMO 
 
CD1d also proved to be expressed in situ on bona fide stroma cells as evidenced by their 
radioresistance in Ubiquitin:RFP mice that have been sub-lethally irradiated and which have been 
reconstituted with C57Bl/6 bone marrow – rendering all non-proliferating cells such as stroma 
endothelium or memory cells fluorescent (see Fig. 3.2.3.1, RFP). 
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As the flow-cytometric analysis of CD1d vs CD45 indicated that CD1d is not restricted to the stromal 
compartment but also expressed on hematopoietic cells, especially antigen-presenting cells. This 
explains why in addition to a stromal overlap (Fig. 3.2.3.2, arrows), a surface staining on hematopoietic 
cells (Fig. 3.2.3.2, composite) can be observed. The nuclei of the stromal show the notable 
pyramid/spindle shape which sets them apart from polymorphonuclear (granulocytes) and circular 
(lymphocyte) and flat (endothelium) phenotypes. 
 
Figure 3.2.3.2: CD1d 
is expressed on 
radioresistant 
stromal cells in the 
bone marrow Femur 
slides of BM chimeras 
where stained for 
CD1d and RFP and 
nuclei (DAPI); arrows 
indicate substantial 
signal overlap on cell 
bodies and processes; 
scale: 50 µm 
 
3.2.4 IL-7+ stromal cells are enriched in CD200int/BP-1+/CD73+/CD105- compartment 
As laid out in section 3.2.1, IL-7 has proven difficult to stain intracellularly at physiological 
concentrations in our hands as well as in the literature. Although the gene-expression and surface 
marker screening approach didn’t reveal an exclusive antigen to stain instead, a characteristic surface 
marker combination shows to enrich for the desired stromal subpopulation (see Fig. 3.2.4). Among the 
many markers to emerge from the screening kit, three were particularly enriched in the GFP/IL-7+ 
stroma cells. Firstly, GFP+ expression was found exclusively enriched in the CD200 intermediate 
fraction. Secondly, BP-1+ and CD73+ seemed to be enriched for GFP+ cells at least. Some stromal 
markers also proved to be mutually exclusive with regards to GFP levels. Endoglin/CD105 for example 
was only expressed on GFP- stromal cells, thus serving as a negative marker of IL-7 stroma. When gating 
on the marker-positive cells among non-hematopoietic cells, GFP+ cells still comprised a considerable 
number of cells for CD200, BP-1 and CD73 arguing for their important role in stromal biology. 
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Fig. 3.2.4: IL7/GFP is 
enriched in CD200intCD249+ 
CD73+CD105- stromal cells 
in heterozygous IL7KI mice 
Dot plots indicating marker 
co-expression with GFP on 
CD45-VCAM-1+ (top row) or 
VCAM-1 expression on 
CD45-Marker+ cells (bottom 
row); samples were further 
gated for viable, non-
lineage singlets 
 
3.2.5 IL-7 abundance feeds back on stromal marker expression unrelated to lack of mature 
lymphocytes 
One of the differentially expressed genes originally identified from the comparison of bulk stroma cells 
and endothelial cells was Cadherin-11, also termed OB-Cadherin derived from its prominent 
expression in osteoblasts. It was later observed to be expressed on reticular stroma as well. 
 
Fig. 3.2.5.1: Cadherin-11 is 
expressed on 
radioresistant stromal 
cells Composite image of 
femoral slides indicate 
substantial signal overlap 
of GFP stroma (green), 
stromal Fibronectin/FN 
(blue) and Cadherin-11 
(red). Arrows: Stromal 
processes that are triple 
positive; scale: 20µm 
While the broad cytometric screening approach of surface markers didn’t yield considerable 
differences between IL7KI haplotypes in the initial experiment, stromal markers BP-1 and Cadherin-11 
revealed a correlation of expression profile and haplotype. Notably, both MFI and percentage of BP-1+ 
cells are considerably higher in the IL7KI-/- haplotype whereas for Cadherin-11 the opposite holds true 
- regardless of whether one looks in GFP+ or GFP- stromal populations. 
As a homozygous knock-in mouse is a virtual knock-out of IL-7 due to absence of a functional wild-type 
allele (as apparent by lack of lymph nodes in the animals), it was hypothesized that the availability or 
rather the absence of IL-7 might feedback to these stromal markers. Another possibility could have 
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been an indirect feedback loop via mature lymphocyte as absence of IL-7 also leads to T and B cells 
progenitors not progressing to mature stages due to their reliance on IL-7 as a survival factor. To 
analyze whether the presence of mature lymphocyte is needed for the observed BP-1/Cadherin-11 
phenotype, the Rag1 knock-out model was chosen. Here, cells can’t recombine their genome for T/B 
cell receptor thus also not being able to progress to mature stages. IL-7 expression by stroma, however, 
is not impaired. 
 
Fig. 3.2.5.2: Differential stromal expression of BP-1 and Cadherin-11 in the presence or absence of IL-7 is not 
due to lack of mature lymphocytes A: Histograms for BP-1 and Cadherin-11 on VCAM-1+PECAM-1- cells 
separated by haplotype and GFP expression B: Histograms for BP-1 or Cadherin-11 expression on 
VCAM-1+PECAM-1- cells of wild-type C57Bl/6 (red line) or RagKO mice (blue line); samples were gated for viable, 
non-lineage singlets; below: percentage and MFI of BP-1+ and Cadherin-11+ cells, respectively; data are mean ± 
SEM 
Surprisingly, when comparing BP-1 and Cadherin-11 levels between Rag KO and wild-type C57Bl/6 
mice no difference can be observed anymore. 
3.2.6 IL-7 expression shows features of monoallelic expression 
Although surface marker expression differences were marginal (apart from BP-1/Cadherin-11) 
between hetero- and homozygous IL7KI genotypes, a striking phenotype with respect to GFP 
expression could be seen in general. Surprisingly and contrary to assumptions the homozygous mice 
didn’t just have higher mean fluorescence intensity due to more GFP being produced per cell but they 
also had a higher overall percentage of GFP+ cells (see Fig 3.2.6). 
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Fig. 3.2.6: GFP levels in IL7KI mice display features of monoallelic expression Left: Representative histogram 
for GFP expression levels in IL7KI heterozygous (blue) or homozygous mice (red); samples were gated for 
viable, non-lineage singlets and indicated population; Center/Right: percentage and MFI of GFP in hetero- & 
homozygous mice; data are mean ± SEM 
 
This is remarkable as a potential explanation might be a generally monoallelic expression pattern 
wherein IL-7+ stromal cells would only or at least partially transcribe only one allele thus resulting in 
higher GFP+ percentage due to stochastics.  
3.2.7 Substantial stroma marker in situ overlap revealed by confocal microscopy & semi-
automated image analysis 
While the confocal microscopy offers the unlimited advantage to get a hold on the in situ lifestyle of 
stromal cells and their nearest neighbors and ECM environment, it comes with the disadvantage that 
at the current state of the art, a staining panel is limited to five fluorescent channels at a time and 
quantification of these pictures doesn’t allow for assessing potential marker overlap apart from 
subjective judgment. There are technological approaches that are aiming to change that in the future 
by repetitively staining and bleaching one and the same histology slide to allow for advanced 
multiplexing. 
As the amount of data from these stainings will only increase, we devised a macro in ImageJ that 
enables us to visually plot two stainings vs each other, mark the overlapping area and quantify these 
single and overlapping areas in a plot similar to a Venn diagram. In addition, the black area inside the 
frame underneath depicts the total image area not occupied by the stainings so that one also gets an 
idea of absolute frequencies and not just those relative between two markers. 
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Fig. 3.2.7.1: Visual quantification of histological overlap of Prx, VCAM-1, CD1d, CD200 and Thy1 in murine bone 
marrow False-color images of 6 µm slides of longitudinally cut PrxRFP femora. Tissues were incubated with 
antibodies against RFP, VCAM-1, CD1d, CD200; antigens are depicted in corresponding colors beneath the image; 
area inside the frame corresponds to all pixels in the image with the contribution of each channel in 
corresponding color and overlap in white; image width: 708 µm 
 
As expected, all stromal markers show a substantial overlap with Prx that serves as the gold standard 
for mesenchymal (hence stromal) identity. It is also not surprising that each of the stromal markers 
display a non-overlapping signal with Prx. The reasons are two-fold. Firstly, most of them are known 
to be expressed on hematopoietic cells as well which is especially obvious in the case of BST2 (on B cell 
progenitors) and VCAM-1 (abundant on granulocytes). Secondly, one has to keep in mind that the RFP 
is a cytosolic protein while the stromal marker stain is a surface stain. This is best accounted for by the 
fact that the soma of stromal cells can only be visualized by Prx but is never visible by surface marker 
stains. 
While the algorithm can serve as a tool to quickly identify overlapping population from high throughput 
imaging, another approach can also be seen in the counterstain of Prx, VCAM-1 and Thy1, respectively. 
Thy1 also known as CD90 is described as a pan-T lymphocyte marker. When compared to the overlap 
of stromal markers, not only is it apparent that the signal contributes less to total pixels but also the 
overlap with Prx is considerably less. Although it appears as roughly 50% in both comparisons on can 
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see from the elongated overlap signals that these are mainly due to vessels where both Prx and Thy1 
are expressed in adjacent pericytes and endothelial cells, respectively.  
An even more advanced approach was developed in coordination with Wimasis to address questions 
beyond mere overlap and colocalization in fluorescent confocal stainings. One such example is 
depicted in Fig. 3.2.7.2 with its original images (A) and corresponding segmentation (B). 
 
 
 
Fig. 3.2.7.2: Advanced image segmentation of hematopoietic and stromal stainings for colocalization and 
overlap analysis Slides of longitudinally cut femora from PrxRFP reporter mice were incubated with antibodies 
against RFP (anti-RFP-Biotin/anti-rabbit-A555, red), CD44 (A488, blue), VCAM-1 (A647, green), Thy1 (A594, 
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white), nuclear staining (DAPI, grey) and transmissive channel for morphology (TPMT on 405 laser), respectively; 
A: stainings in separate channels; B: Image segmentation of corresponding images in A provided by Wimasys was 
run and recognized structures marked in varying colors (DAPI: nuclei encircled in red, CD44: surface expression 
intensity was graded from green to red, VCAM-1: irregular shapes from stroma were marked in red while circular 
granulocytes are marked blue, Prx: irregular signal was marked in red while stromal soma are marked blue, Thy1: 
circular single cells were marked in red while clusters are denoted green and elongated macro-structures blue); 
Scale: 50 µm 
3.2.8 Stromal markers are conserved between organs but depict less compartmentalization in bone 
marrow 
While the overall focus of this thesis was to determine the heterogeneity within the bone marrow 
stromal cells, the original interest in the stromal cells stemmed from the fact that the bone marrow 
seemed to be a preferential homing and maintenance place for memory lymphocyte precursors. Hence 
the very initial question that arose was what differentiated a splenic stromal cell from that of the BM. 
A staining panel that elucidates these differences is one including Annexin A2, gas6 (growth arrest 
specific 6) and CD1d. Gas6 (fold change: 19) was originally identified as differentially higher expressed 
genes in the bulk stroma vs endothelium analysis (see section 3.1.4). 
Annexin A2 is considered a pleiotropin106 but has been implicated in the stromal HSC niche due to its 
interactions with CXCL12107, 108. gas6 was similarly correlated to improved HSC maintenance by in vitro 
data and was found to exert its effect via cell-cell interactions109 through its cognate receptors 
Axl/MerTK/Sky110. Both gas6 and ANXA2 have been linked to the homing and dormancy induction of 
prostate cancer cells to the bone marrow111. 
The staining in the bone marrow visualizes the vast reticular stroma pattern that is typically observed 
in the bone marrow with extensive overlap of the three markers on stromal processes (Fig. 3.2.8, top).  
The same staining in the spleen does reveal that the markers are expressed there as well but whereas 
Annexin A2 is almost as equally spread as in the BM, gas6+ and CD1d+ stroma cells are localized in a 
very distinctive pattern (Fig. 3.2.8, bottom). This becomes especially visible with regards to the follicles 
(Fig. 3.2.8, dashed circle). While gas6 is exclusively expressed outside of them, CD1d is enriched on 
cells of the follicle boundaries. 
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Figure 3.2.8: Organ-specific compartmentalization of stromal cells in murine bone marrow and spleen Slides 
of longitudinally cut femora and spleen from B6 mice were incubated with DAPI (white) and antibodies against 
Annexin A2 (ANXA2, green), gas6 (red) and CD1d (blue); dashed circles indicate a follicle; scale: 200µm 
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3.2.9 A potential role for Annexin A2/ Annexin A2 receptor for the homing and interaction of stromal 
cells and HSCs and B cell lineage 
Since Annexin A2 was identified to be expressed on stromal cells and colocalize with a handful of 
markers (including CD1d and gas6) and was implicated in the literature to play a role in the homing 
and attachment of prostate cancer cells in the bone marrow we hypothesized that it might also play a 
role in physiological interactions of lymphocytes and stroma cells. Initially assuming that its cognate 
receptor ANXA2R might be expressed on memory T lymphocytes (Thy1+CD44hi) did not appear to be 
the case (Fig 3.2.9.1A). It even seemed not to be expressed on the T lymphocyte lineage at all. 
 
 
Fig. 3.2.9.1: Annexin A2 receptor is almost exclusively expressed in the B lymphocyte lineage in the bone 
marrow    A: Histological slides from C57Bl/6 femora were incubated with antibodies against Annexin A2 receptor 
(ANXA2R, green), Thy1 (red), CD44 (blue); B: ANXA2R (green), B220 (red), IgM/IgD/κ + λ light chain (light grey); 
white circle: rare phenotype of B220-ANXA2Rhi(IgM-IgD-κ/λ-) cell; scale: 50 µm 
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Notably, when counterstained with B220 to account for all of the B cell lineage except for plasma cells, 
it showed a high degree of colocalization with B220 (Fig. 3.2.9.1B, composite image). 
While no further analysis was pursued to narrow down the hematopoietic populations wherein 
ANXA2R is expressed, it should be noted that an infrequent phenotype that could be found in those 
stainings was that of a B220-ANXA2Rhi(IgM-IgD-κ/λ-) cell (Fig. 3.2.9.1B, white circle). Whether this could 
be HSCs or downstream, uncommitted lymphopoietic progenitors remains to be elucidated. 
Another recurring observation (n=4) was that ANXA2R+ cells that seemed to be in the vasculature of 
the bone marrow as outlined by lining CD1d stroma pericytes and lack of adjacent DAPI signal always 
had a substantially higher surface signal (ANXA2Rhi, Fig. 3.2.9.2, red circles) compared to those within 
the tissue (Fig. 3.2.9.2, green circles). 
 
Fig. 3.2.9.2: ANXA2R 
surface expression is 
higher in vasculature-
borne cells than tissue-
resident in murine bone 
marrow Representative 
slide of longitudinally-cut 
femora from C57Bl/6 mice 
(n=4) were stained for 
ANXA2R (light blue), CD1d 
(yellow) or nuclei 
(DAPI/purple); red circles: 
ANXA2Rhi cells in 
vasculature; green circles: 
tissue-resident ANXA2Rlo 
cells; Scale: 50 µm 
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4 Discussion 
The initial goal of this study was to enhance the isolation outcome of VCAM-1+ stromal cells from fresh 
murine bone marrow. An early increase could be achieved by digesting flushed bone marrow and 
empty bone independently from each other and combine suspensions afterwards as implied in earlier 
work of our group112. Due to their strong adherence to plastic surfaces formerly used for cultivation 
purposes the cytoskeleton was targeted in a subsequent attempt to recover stromal cells after 
digestion. The F-actin destabilizing agents Cytochalasin D and Latrunculin B could increase the recovery 
furthermore. The enhanced protocol enabled broader investigation of stromal cells in general. On the 
one hand, stromal cells were sorted to elucidate their gene expression profile and to gain insight into 
their commitment to several subsets. On the other hand, and partially in conjunction with gene 
expression data, several surface markers known to be expressed on stromal subsets were stained in 
flow cytometry and histology.  
Histological quantification of Prx reporter mice long bones showed that stromal reticular cells make 
up about 2% of total nucleated bone marrow cells. It needs to be noted that this estimate is rather a 
conservative one as it doesn’t account for bone lining osteoblasts and might have missed some 
pericytes as those don’t have the “extended/dendritic” phenotype that is typical for PrxRFP+ cell bodies 
of reticular stroma. Nevertheless, initial isolations fell even short of this goal by yielding less than 0.1% 
of CD45-VCAM-1+ cells among all live Ter119- cells analyzed. The major hindrance during isolation 
seems to be their embedding in extracellular matrix which was subsequently addressed by a set of 
digestion enzymes with which cells are incubated. Their susceptibility to mechanical stress might as 
well be attributed to the rupture of gap junctions that are expressed on mesenchymal stroma113. 
Stromal cell-derived stem cells are plastic-adherent as shown by Friedenstein and coworkers11. This 
issue was addressed by adding F-Actin destabilizing agents Cytochalasin D and Latrunculin B. 
Surprisingly, as they both have different working principles of disturbing cytoskeleton integrity, their 
influence on stromal yield is different. In other words, depriving the cell of G-Actin (Latrunculin B) 
seems to be more efficient than capping already formed filaments (Cytochalasin D). This is even more 
notable as serum-sensitive effects of Latrunculin B cannot be excluded in these experiments. It can 
also be ruled out that this effect is simply contributed to toxicity of the compounds as percentages in 
viability didn’t differ drastically.  
However, both reagents were chosen for digestion as they were shown to synergize97. The reversibility 
of their action leads to the question whether cells might be lost due to adherence again after 
subsequent washing steps. This issue hasn’t been addressed in the scope of this thesis but is worth 
pursuing although reversing kinetics for stromal cells are not known so far. It could however be 
observed that bone marrow that was objected to a digestion including inhibitors took longer to 
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reattach on plastic surfaces after plating compared to BM digested without additives (data not shown). 
Hence, the effect seems to be prolonged enough not to cause cell to attach again after switch to LatB-
free buffers. 
In the next step, cell suspensions obtained with the improved protocol were stained for VCAM-1 and 
Lineage markers to be sorted via FACS™ in the following step. Although sufficiently pure fractions of 
VCAM-1+PECAM-1+/- could be sorted, the recovery was far from complete. As a result of the rare 
phenotype of stromal cells in full bone marrow, sorting of BM from one mouse took approximately 
1.5h. Hence, some cells might have died due to sedimentation in the sample tube or sorting tubes. 
System-wide cooling of the tubing system was applied to address this issue. In addition, the sample 
tube was resuspended repeatedly to avoid density-related effects. Applying isopycnic sample medium 
can be another suitable approach to further prevent sedimentation from happening in the future. 
Initial tests with Percoll-adjusted sorting buffer proved feasible and didn’t influence the fluidics or 
stainings despite increased viscosity of the suspension (data not shown). 
Besides optimization of the isolation protocol the biological question of this thesis ultimately was to 
shed light on the heterogeneity of murine bone marrow stromal cells. Due to the diversity of stromal 
markers published and used for proper isolation, this thesis first focused on VCAM-1. VCAM-1 has been 
described to be expressed on stromal cells supporting the maintenance of several long-lived or 
memory lymphocyte subsets in vivo114. Interestingly, the stromal subsets do seem to overlap but not 
always co-express survival-promoting signals (IL-7 or CXCL12 for CD4 memory or long-lived plasma 
cells, respectively). With the memory niche concept possibly applicable for other lymphocyte subsets 
as well, bone marrow stroma becomes an interesting target to characterize.  
It has been well recognized in recent years that the infection route of antigen matters resulting in 
tissue-resident, topological memory lymphocytes as a first line of defense for future encounters115, 116. 
However, our group established that memory lymphocytes for systemic antigens like Measles, Mumps 
and Rubella (MMR) seem to favor homing to the bone marrow over other organs for the resting 
phase117. Although some argued that the bone marrow is a calm environment that favors resting 
populations, the very fact of thriving hematopoiesis and even acute phase in situ proliferation118 has 
called that assumption into question. Still, it seemed rather inefficient that especially plasmablasts and 
long-lived plasma cells should relocate from spleen to BM. Hence, our initial question to be addressed 
with the stromal cells was that of genotypic and phenotypic differences between common splenic 
stromal cells119 (FRC, MRC, FDC) and BMSCs. Unfortunately, at the time of generating these 
transcriptomes, we were not able to obtain sufficient numbers of VCAM-1+PECAM-1- stromal cells from 
the spleen. In an attempt to at least understand BMSC signature gene expression, micro arrays were 
prepared from stromal PECAM-1- versus endothelial PECAM-1+ cell RNA. As both originate from 
Lenz, Daniel  4 Discussion 
42 
 
different germ layers (mesoderm versus endoderm, respectively), a vastly differential expression was 
expected beforehand and verified in the results.  
Genes that are significantly higher expressed in PECAM-1- cells seem to confirm their multi-lineage 
differentiation potential. Being able to give rise to adipocytes, osteoblasts and chondrocytes among 
other mesenchymal cell types led to the term “mesenchymal stem cells” for their in vitro cultured 
counterparts120.  Of the lineage commitments observed for stromal cells in the bone marrow the most 
prominent relate to osteoblasts and adipocytes. Of importance is the transitional phenotype of some 
genes differentially expressed. Adiponectin or Follistatin-like 1 for example are expressed at highest 
on pre-adipocytes both decreasing rapidly upon further commitment54, 121. As for the early adipocyte 
markers one needs to take into account that cytoskeleton-destabilizing agents such as Latrunculin B 
and Cytochalasin D might have side effects on the cell physiology. As the shape of the cell changes 
adipogenesis is likely to be triggered53, 54, 122.  This was further corroborated by the enriched gene sets 
of cell adherence. Although the time scale for the morphological transition is not reached within the 
experiment, transcriptional upregulation of genes could be triggered this early. Such side-effects could 
be prevented by addition of Actinomycin D in all buffers to block de novo transcription in future studies. 
That could additionally rule out effects by exposing the cells to normoxia when they have been shown 
to reside in a tissue of pronounced hypoxia41, 123, 124, 125. 
The early committing phenotype might also be true for the osteogenic lineage that is reportedly 
induced by FGFR2126, 127 and/or Cadherin-11 together with N-Cadherin128, 129. Nevertheless, the 
osteoblast phenotype is more pronounced with maturity markers such as bone sialoprotein, 
osteopontin or osteoglycin being highly expressed. However, this observation could only be confirmed 
for runx2 on the master transcription factor (TF) level but not for the hallmark TF osterix. A common 
concern of course is that of exclusivity of markers for certain lineages as Cadherin-11 could be shown 
in this thesis to be expressed on reticular stroma as well and lineage-tracing with Osterix shows 
Osterix+ cells contribute to reticular stroma perinatally130. So it is not surprising to find genes known to 
inhibit osteoblast maturation (e.g. SFRP4131, 132, IGFBP5133, 134) are expressed at the same time. This 
finding - together with the presence of adipocyte, myoblast/vSMC and chondroblast markers - hints at 
a highly versatile and multi-lineage stromal cell pool.  
In line with the introductory outline of VCAM-1+ stromal cells as bone marrow niche supporting cells, 
one can confirm the expression of the corresponding survival signals CXCL12, kit ligand and IL-7. The 
latter was found to be expressed at low yet differential levels matching earlier reports135.  
Considering the successful isolation of bulk stromal cells, another issue to be addressed is their survival 
ex vivo. An important step is the sorting procedure at the FACS™ devices. There, cells pass nozzle with 
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a diameter classically being around 60 µm. Given the sheer stress susceptibility even in the 
cytoskeleton-disturbed condition, switching to higher nozzle diameters such as 100 µm proved 
beneficial for viability after sort (data not shown). The disadvantage in such a scenario however was 
that as sorting speed is limited to 2000 events per second, a pre-enrichment becomes necessary 
further impacting on the recovery of stromal cells. 
Despite having isolated seemingly pure populations of GFP+/- stromal cells from the IL7KI reporter mice, 
we were surprised to find a majority of leukocyte contaminating genes in the differentially regulated 
genes. The fact that the Il7 transcript seemed to be present in both sorted fractions made us 
additionally cautious. Different possibility arose from the finding. Firstly, we could have had GFP+ cells 
contaminate our GFP- population. This was considered unlikely as the clustering still worked perfectly 
and the sort check didn’t show any GFP+ cells in the GFP- fraction. It is possible that GFP+ cells lose their 
GFP fluorescence signal during sorting due to quenching or proteasomal degradation. Secondly, 
monoallelic expression is possible and would serve as an explanation how a cell could transcribe from 
the wild-type allele without having to use the knock-in allele. We could see that this is also implied by 
the GFP expression shift between IL7KI heterozygous and homozygous animals. In case of a biallelic 
expression pattern, only the GFP mean fluorescence intensity should change as more GFP would be 
expressed per cell. What we do find is that not only the MFI changes but the percentage of GFP+ 
stromal cells as well. This rather fits to the assumption that at least some cells express IL-7 
monoallelically which in the homozygous setting would manifest in higher probability of cells choosing 
the knock-in allele as observed. Further work needs to be done to further explore that claim but 
preliminary follow-up experiments seem to confirm the monoallelic expression that is well known by 
other members of the IL-2 family136 (Richard Addo, unpublished data). 
The last and equally likely scenario to explain the Il7 signal in the GFP- sorted transcriptomes is the 
probe design. From what we could determine, Affymetrix designed their probes in Exon 3 or 4 of the 
Il7 gene which are both unaltered in the wild-type (WT) and knock-in as the insert is directly after 
Exon 1 (see Fig. 3.2.1A and unpublished data, Richard Addo). Regardless of the shortcomings of those 
transcriptomes it was surprising to see Prx (Prrx1) as the only HPCDA-ranked gene to be higher 
expressed in the GFP+ sorted fraction. Assuming that the signal was not just diluted out by leukocyte 
genes in GFP-PECAM-1- cells, it would mean that the mesenchymal master transcription factor is higher 
expressed in the presumed IL-7+ cells. As the Prx reporter mice are designed as a terminal excision by 
cre/loxP system, we were lacking information up to what point in differentiation stromal cells 
expressed Prx. Recent data implicating it in the inhibition of adipogenic137 and osteogenic138 pathways, 
respectively, argue for a role of Prx as a correlate of stromal “stemness”. It is thus intriguing to see the 
expression of the survival niche factor IL-7 in such an “undifferentiated” population in the bone 
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marrow. It will be interesting to see whether Prx will be equally enriched in another sorted stromal 
subpopulation and since the advent of single-cell sequencing especially on a per-cell level. 
When looking at the results of the surface marker screening kit of heterozygous vs homozygous IL7KI 
mice, one has to keep in mind that by definition and history, the CD nomenclature is biased towards 
hematopoietic cells. The manufacturer even markets it for that purpose. Hence, although we did get 
an unbiased screening approach, it was to be expected that not all included markers would be 
expressed. Furthermore, the results of the screening need some cautious consideration: Since we 
pooled bone marrow stroma from 3 different mice each and compared two different haplotypes, the 
total cell number for each stain was rather low (approx. 105 cells). Still, the studied stromal and 
endothelial populations could clearly be considered statistically as such at a minimum of 200 cells/ 
CD45-VCAM-1+ gate. It cannot be ruled out that the individual mice contributed different populations 
to the analysis. However, assessing variation between individuals was not the scope of the approach. 
In addition, the manufacturer provided the antibodies as is in a pre-titrated fashion that might be 
suitable for hematopoietic suspensions but not for rare cells like stroma. We adjusted the gates for 
FMO and isotype controls to account for that fact. Finally, as the staining was carried out in a 
multiplexed fashion, the staining procedure was harmonized for all antibodies, i.e. performed on ice. 
For some markers, especially chemokine receptors (CCRs, CXCRs), manufacturers and scientists 
recommend staining at 37 °C to increase brightness. Hence, signal intensity with these antibodies 
might underestimate expression or introduce unwanted background. 
Despite these confounding variables, it was still rather surprising to find the expression of more than 
25 surface markers, some of which have never been linked to stromal cells or non-hematopoietic cells 
in general. The functional implications depend on the corresponding molecule.  
CD1d is a non-classical member of the MHC family and present lipids to NKT and to a lesser degree 
γδ T cells, especially by professional antigen-presenting cells139, 140. This partially reignites the 
discussion in the field whether stroma cells are bona fide antigen-presenting cells. It is known that 
while they don’t express MHC II in steady state, they quickly upregulate its expression after exposure 
to IFNγ141, 142, 143. This conditional expression appears to be beneficial in a systemic inflammation setting 
but CD1d in contrast is expressed constitutively. NKT cells don’t require peripheral CD1d/TCR triggering 
for their survival but rely on IL-15 and IL-7 for homeostasis144 much akin to CD8 memory lymphocytes145 
(where the concept is debated146, however). Whether that entails competition for a similar niche 
would be in interesting question. Another member of the CD1 family, CD201/EPCR, was found to 
expressed on stroma cells as well. While it’s not involved in lipid presentation to NKT cells it has been 
shown to play a role in HSC maintenance147, further adding to the list of well-described interactions 
there. 
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A prominent category of markers expressed encompasses cell-ECM and cell-cell adhesion. Most 
notably, we find substantial expression of the Integrin subunits αM (CD11b), αV (CD51) and α1/β1 
(CD49a/CD29) of the VLA1 heterodimer. The latter is important for binding to a variety of Collagens 
and Laminin. Integrin αV is a common subunit of dimers binding to vitronectin, fibronectin or – like 
CD105/Endoglin – to TGFβ1-3. Integrin αM was shown to bind ICAM-1 (CD54) which is also produced 
by a subpopulation of stroma identifying a possible new stroma-stroma interaction. Like ICAM-1, CD44 
is a very broadly expressed glycoprotein capable of binding fibrin, fibrinogen, and hyaluronan. Other 
targets exclusive to CD44 include Osteopontin and Selectins due to its diverse glycosylation patterns. 
One such glycoform (HCELL) could even be shown to confer bone marrow homing to transferred 
MSCs148 much like the CXCL12/CXCR4 axis. CRTAM, which only shows a very minor population in the 
GFP- stroma cells was only recently described to be essential for epithelial and fibroblast cell 
adhesion149. Another member is CEACAM-1 (CD66a) that has been implicated in homophilic and 
heterophilic interactions on epithelia, endothelia and leukocytes. Surprisingly, it also shows interaction 
with Annexin A2. CD24 is a cell adhesion molecule that has been studied as a differentiation molecule 
in lymphocytes. Its absence predisposes mice to developing EAE150 implicating a protective role in 
autoimmune diseases. Sialoadhesin/Siglec-1 (CD169) binds to sialic acid modifications of surface 
proteins on other cells. It has been implicated on macrophages in the retention of HSCs in the niche151. 
CD9 and CD63 are members of the tetraspanin family and found on a variety of cells, including nerve, 
muscle cells and many cells of hematopoietic origin. CD9 is found to participate in forming a large 
molecular cell complex with other member proteins (e.g. MHC class II, CD19, CD5 etc.) and could be 
beneficial in case of antiviral responses. CD9 was reported to be expressed on human progenitor MSCs 
recently152. CD63 is enriched on exosomes and MSC exosomes proved immunosuppressive in an uveitis 
model153. 
CD73 is known as an ecto-enzyme converting AMP to Adenosine and Phosphate. While it has been 
shown to be expressed in MSCs and osteoblasts154, 155 it is more classically known from lymphocyte 
differentiation156 and recently (cancer) metabolism and immune suppression157, 158. Since stromal cells 
and their in vitro MSC descendants in particular are known to be immunosuppressive in physiological, 
transplantation and co-transfer settings159, the expression of other markers than CD73 known to be 
involved in these pathways (CD24150, CD200160, CD55161, TIGIT162, Tim-1163, CD160164, 165, PD-1166, 
Galectin-9167, 168, 169) broadly recapitulates this phenotype on the population level in our hands although 
we cannot yet comment on the overlap between these populations. What is remarkable though, is 
that almost all of these inhibitory markers (with the exception of CD73) show a mutually exclusive 
expression with regards to IL-7/GFP. This distinction seems to be plausible for the dual biological roles 
stromal cells have been implicated in. On one hand, they favor survival and expansion of hematopoietic 
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precursors, especially of HSCs and the B cell lineage. On the other hand, they are known to suppress 
proliferation & induce quiescence. Separating these factors – receptors & ligands alike – 
spatiotemporally might keep that delicate balance in check in the bone marrow. Of those inhibitory 
markers expressed by a subset of GFP- stromal cells CD55/DAF stands out as it is entirely absent on 
homozygous IL7KI reporter BMSCs. There is no mechanistic link that readily explains this in the 
literature. But since DAF was shown to modulate T cell activation by quenching T- and antigen-
presenting cell (APC)-derived C3a/C5a170, 171, it might simply be the absence of mature T lymphocytes 
that abrogates the upregulation of DAF in the first place.  
This, however did not seem to be the case for BP-1 and Cadherin-11 that showed differential 
expression between IL7KI haplotypes. Because we assumed that if the absence of mature lymphocytes 
is the cause for the different expression modes, a RagKO mouse where recombination/maturation of 
lymphocytes is similarly stalled should recapitulate the observed phenotype. Although that wasn’t the 
case, an additional puzzling aspect was that although the WT vs RagKO staining of Cadherin-11 was 
similar, the percentage (20-30% Cadherin-11+) rather reflected the level previously observed in the 
IL7KI-/- mice in contrast to the expected heterozygous percentage (70-80% Cadherin-11+). It remains to 
be shown how Cadherin-11 might be linked to IL-7 expression in the IL7KI setting. While BP-1 did show 
the same expression between heterozygous IL7KI, wild-type and RagKO it has both higher percentage 
and MFI in the homozygous BM stroma. In B cell progenitors it is upregulated after IL-7/IL-7R 
signaling172, hence would be expected to display a lower MFI in the homozygous haplotype. We did 
however not find any CD127/IL-7Rα chain expression in the surface marker screening on either 
haplotype (data not shown). Thus - assuming that absence of CD127 is not due to recent engagement 
with IL-7 and/or due to its absence - what is upstream of BP-1 in stroma is unknown. It should also be 
noted that the mice for the surface marker screening were considerably younger compared to those 
from which different BP-1 and Cadherin-11 expression could be observed. Considering how flexible 
contributions to the stromal niche are perinatally already130, it cannot be ruled out that a phenotypic 
change takes place within stroma during aging in line with clear-cut differences of MSCs isolated from 
young vs old donors/mice173. 
CMKLR1 (ChemR23) was previously described as an adipokine receptor in white adipose tissue 
together with its ligand Chemerin174. Chemerin in turn is negatively regulated by Prx137. When 
expressed on macrophages, mainly on M1 polarized cells, it can be detrimental for inflammation or 
beneficial depending on the ligands it binds175. Since it can heteromerize with CXCR4 and CCR7, 
negatively regulating their affinity for their respective ligands176, it is likely that the small subset of 15%  
will have an altered signaling threshold with regards to these pathways. 
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Despite a strict lineage (CD45, Ly6G/C, B220) exclusion gating strategy we were surprised to find a 
variety of markers expressed on stroma cell subsets that are commonly attributed to plasmacytoid 
dendritic cells (pDCs) in the mouse. That is true for BST2/PDCA-1, PDC-TREM, CCR7 177. The broad 
myeloid Integrin αX (CD11c) was not expressed on stroma (data not shown). As counterstains are not 
available one can only speculate whether these markers are co-expressed on the same cells. Taken 
together with the fast Interferon response of BMSCs and their ability to upregulate MHC II in infection 
settings178 an antiviral functional overlap between these two distinctive lineages would be intriguing, 
surely. The question that remains is why chemotactic receptors like CCR7 or CCR3 (rather known from 
eosinophils) are expressed on immobile stroma cells at all – assuming the staining is accurate. A 
possible hint comes from the fact that BMSCs have been implicated as motile osteoprogenitors that 
provide a local pool of osteoblast precursors in bone fracture settings179 in line with their description 
as stem cells. Since an early fracture is usually accompanied with tissue-damaged induced 
inflammation, this set of markers might lead to adequate homing of BMSCs to sites of injury. 
Similar to CXCL12 and IL-7, APRIL/CD256 was identified as a survival factor for plasmablasts in the bone 
marrow180. Apart from this function it appears to be dispensable for the immune system as APRIL-
deficient mice develop normally181. While its secretion is usually attributed to macrophages in a 2D 
in vitro enrichment of adherent primary BMSCs180, these experiments might miss the in situ expression 
of APRIL on stromal cells due to loss of ECM/3D structure & physiology akin to CXCL12182, 183. While 
only present on 10-15% of ex vivo stromal cells, their presumably equal distribution and embedding in 
the marrow makes them better niche-providing cells than mobile macrophages. 
Ultimately, the surface marker screening could reconfirm some stromal populations described in 
literature (CD106/VCAM-1, CD140a/b, CD73, CD200/OX2, CD54/ICAM etc.) but also identified new 
stroma populations hitherto unknown on BM stroma (CD1d, CD55) and some to be downriched in 
absence of IL-7 as achieved via IL7KI haplotype. It needs to be noted, however, that these findings are 
far superior to previous studies in elucidating the in situ phenotype in that we obtained the data for 
freshly isolated ex vivo BM stromal cells. Previous studies have looked at whole-population lysates and 
subsequent mass spectrometry152 or analyzed plated and/or passaged MSCs (hence depleted of non-
adherent cells) and have since changed their proliferation status, surface marker phenotype and 
size184. 
Since the advent of the “-omics” approaches in life sciences the amount of data that is generated with 
each experiment continuously surpasses what is manually feasible to analyze. That was also true in 
two scenarios during this thesis and the reason for cooperation with DRFZ bioinformaticians Pawel 
Durek and Ralf Köhler, respectively. 
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Together with Pawel Durek, we addressed the question how our knowledge of the niche constituents 
– namely stroma and memory lymphocytes – could be exploited from their corresponding 
transcriptome data that was readily available in our group. In short, we were looking for possible 
overlooked ligand-receptor interactions from either cell type. This approach of course has limitations. 
As we have to rely on curated lists of ligand/receptor interactions, orphan candidates might be missed. 
Additionally, the algorithm still needs some refinement with regards to homotypic interactions and 
cis/trans-binding, i.e. that the same molecule on one cell type shouldn’t be detected as a pair and 
possible ligand/receptor pairs on one cell shouldn’t be counted as an interaction with the other cell, 
respectively. 
We faced a similar hurdle during overlap analysis of histological stroma marker stain. Histology in 
contrast to flow cytometry suffers from a subjective bias when it comes to adjusting the image 
acquisition settings and subsequent comparison of image files from different stains. That is not to say 
that histology is not set in accordance to an isotype control and to maximum brightness distribution. 
But especially in stromal histology, we are interested in the filigree processes of the reticular stroma 
which at times requires oversaturating part of the image to get the full scope. Hence, we devised an 
ImageJ macro with Ralf Köhler from the Hauser lab that can automatically extract channels from *.lsm 
files convert it to binary by thresholding, due a pixel-by-pixel overlap analysis and present the results 
as false-color histology as well as Venn diagram overview. This way, manual input is minimized to the 
settings on the microscope. The macro is limited by the fact that it quantifies entirely on a per-pixel 
basis. The problem is apparent when looking at the stainings of VCAM-1, BST2 and Thy1, respectively. 
All three have stromal contributions but show a considerable expression on hematopoietic cells as 
well. Any overlap/colocalization macro will hence severely over-/underestimate the actual stromal 
marker overlap with these markers. Here, segmentation – i.e. the trained recognition of particular 
image/cell features will need to be implemented in the future. This was actively started with Ralf 
Köhler and in corporation with Wimasis, Munich. 
An exemplary staining with subsequent segmentation can be seen in Fig. 3.2.7.2. Besides DAPI, it 
includes Prx and VCAM-1 to assess stroma cells and Thy1 and CD44 for T cells in general and the 
Thy1+CD44hi pool in particular (Fig. 3.2.7A). The segmentation of each channel is provided in Fig. S4B. 
In addition to simply detecting and counting nuclei (DAPI), the segmentation can rank CD44 signal per 
cell by expression level as we are most interested in CD44hi cells of a memory phenotype. Also, it can 
separate the hematopoietic (VCAM-1, blue) from stromal (VCAM-1, red outline) VCAM-1 signal. 
Equally, it is possible to assess Prx cell bodies (Prx, blue outline) and processes (Prx, red outline) 
separately. Thy1 is even more complex. As previously mentioned, Thy1 is expressed on T cells as well 
as arteriolar cells. The elongated arteriolar contribution (Thy1, blue outline) can thus be separated. 
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Additionally, a recurring observation with Thy1 in the BM is that both singular cells (Thy1, red outline) 
as well as clusters can be found (Thy1, green outline). This advanced segmentation could thus answer 
questions in the direction of whether memory T cells are more frequently found in clusters and 
whether those rather colocalize with Prx cell bodies or processes which can help in formulating better 
hypotheses to test in subsequent experiments.  
We hope that it will be useful beyond this thesis as a potential use case was already considered the in-
house multi-epitope ligand cartography (MELC) that the Hauser lab developed. There, histology can be 
multiplexed by repetitive staining and bleaching of antibody conjugates. 
Annexin A2 and its cognate receptor ANXA2R seem to be a promising new ligand-receptor interaction 
between stroma cells and the B cell lineage according to the preliminary findings of this thesis. While 
it remains to be clarified which B cell progenitors do express the receptor and whether it plays a role 
in the homing and maturation of these cells. It would come as no surprise to see that lymphocytes 
make use of the same mechanisms as has been described for prostate cancer cells in the bone marrow. 
There, the triad of CXCL12/CXCR4, ANXA2/ANXA2R and gas6/Axl is supposed to keep the cells in 
place107, 108, 185. Keeping in mind how important CXCL12 is for B cell progenitors this insinuates a viable 
hypothesis to test. As for the differential surface expression levels that coincide with their localization 
in or out of the vasculature, one could equally argue with a crosstalk of CXCL12 and ANXA2. CXCL12 is 
most highly expressed in the bone marrow stroma while its concentration drops sharply in the 
vasculature. What the functional relevance of this mechanism is remains elusive. 
The two paramount aims of this project were, firstly, to understand what makes the bone marrow a 
preferential homing organ for memory lymphocytes compared to spleen or liver and secondly what 
separates a benign/protective bone marrow niche from a malign/autoreactive one in an autoimmune 
disorder and whether there even is such a difference as the cells could be qualitatively the same except 
for constant antigen exposure. While this thesis cannot comment on the latter question, initial 
comparative stainings of some stromal markers (CD1d, ANXA2, gas6) have shown that the key to 
understand stroma biology might lie in their (co-)localization and compartmentalization in the 
respective tissue. It is true that splenic follicles have no counterpart in BM and memory niches lack 
considerable representation in spleen, making these presumptions fallible. What the depicted 
stainings show, however, is that in general majority of markers are present in each of the tissues but 
not necessarily on the same cells. The bone marrow seems to be unique in that regard as the broad 
overlap or at least proximity of markers seems to be decisive in enabling niches. As a considerable 
reservoir of memory B cells in the human spleen186 and tissue-resident memory lymphocytes show, 
one should not be too stringent in calling the bone marrow the sole harbor of immunological memory. 
It helps to keep in mind that the HSC niche, for example, adaptively relocalizes in mammals several 
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times during embryonal development (yolk sac --> aorta-gonad-mesonephros --> fetal liver --> bone 
marrow medulla) and can even be extramedullary in physiological and pathological conditions 187. This 
implies that no “one/restricted” cell type is capable of providing niches but comparison between those 
stages might elucidate minimal requirements. 
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5 Outlook 
Having identified a variety of markers – among them many previously attributed to hematopoietic cells 
– on stromal cells, this thesis contributed to the deeper understanding of how the stromal network of 
the murine bone marrow might shape the hematopoietic environment and development in the 
crowded microcosm that is the bone. 
It remains to be seen how many of the markers identified herein show an equal expression pattern on 
human stromal cells, however. Empirically, it can be expected that not all will be expressed and if they 
are, their functions might differ. A good example for that is CD105 in the human where it is considered 
a bona fide stroma marker while in the mouse it almost exclusively localizes to endothelial cells. 
Another aspect this work could not address due to time constraints is the kinetics and overall time 
course of the marker expression with age and for example in an acute immune reaction. Considering 
the well-established fact that HSCs get a myeloid skew the older the mice get and that this process has 
been linked to stromal contributions188 such as an intrinsic adipogenic skew189, 190 , it would only be 
logical to assume that the overall stroma expression pattern varies and feeds back to environmental 
cues. In the concept of “inflamm-aging”191, aging and an acute immune reaction can even be linked to 
one another. That genomic damage seems to contribute to a similar degree becomes obvious from 
how well irradiation damage recapitulates the “old bone marrow” phenotype192. Future fate-mapping 
studies will likely contribute to our understanding in this regard. 
Rather omitted from this thesis but seemingly a consequence of the architecture of the bone marrow 
is the finding it might be fundamentally wrong to treat stroma cells as multiple isolated cells sitting 
together in a shared ECM entirely detached from the rest of the body. It should not be forgotten that 
stroma cells are tightly inter-connected by gap junctions, i.e. Connexins which are even implicated in 
modulating CXCL12 secretion193, 194, 195. Now if you consider a network that can easily exchange second 
messengers and hormones196 the question arises why you would even expect clearly separated 
populations in the first place as all cells are eventually subjected to differing degrees of the same 
stimulus in this setting. It is true that the clear-cut sub-population view is reinforced by observed 
bimodal distributions from flow cytometry but it wouldn’t be too surprising to learn that stromal 
marker expression is in a spatiotemporal flux in response to external stimuli from ECM and 
lymphocytes as the IL-7 data imply. Notably, the concept of stable maintenance in a niche is 
irreconcilable with a flexible stromal network so it remains to be shown how these interactions that 
can last a lifetime in humans (as evidenced by stable childhood disease antibody titers197, 198) survive 
the turbulent surroundings of the bone marrow. 
 
Lenz, Daniel  6 Supplement 
52 
 
6 Supplement 
Tab. S1: Overview of RNA quantity and quality from FAC sorted sub-populations of bulk stroma cells 
Sample # mice CD45-VCAM-1+PECAM-1- CD45-VCAM-1+PECAM-1+ 
RNA content [ng] RIN RNA content [ng] RIN 
1 3 135 8.0 89 8.2 
2a 2 63 8.6 80 7.8 
2b 3 56 61 
3a 2 69 5.0 68 8.9 
3b 2 63 60 
 
Tab. S2: Significantly differentially expressed genes in VCAM-1+PECAM-1- BMSCs in comparison with 
VCAM-1+PECAM-1+ control cells ranked by HPCDA score Table denotes gene (first column) and corresponding 
originating tissue (second column); multiple appearances of a gene indicate more than one positive probe-set; 
Sig S: mean corrected signal intensity of PECAM- chip samples; Sig E: mean corrected signal intensity of PECAM+ 
chip samples; FC: fold change; data is derived from 3 different experiments 
Gene Expression site Sig S Sig E FC HPCDA-
Score 
MMP13 stroma199, 200, osteoblasts201 17306 32 1626 51989 
C1 inhibitor  fibroblasts202, megakaryocytes/ 
platelets203 
22611 113 182 44026 
Insulin-like growth factor binding 
protein 5 
myoblasts204 30651 195 134 35428 
Adiponectin pre-adipocyte205 16823 86 172 31284 
Ceruloplasmin stroma206 12869 38 243 25294 
CXCL12 stroma207 32047 430 82 22717 
Cytochrome P450, 1B1  adipocytes208, 209, vSMCs210 12672 30 528 22468 
Bone sialoprotein  osteoblasts 16796 82 188 20817 
Tenascin C  osteoblasts211 14317 74 203 18964 
Osteopontin  osteoblasts, osteoclasts 24785 160 164 16416 
Procollagen  I, α2  osteoblasts212 22068 187 128 15724 
PTPRD  pre-B cells213 5900 38 135 13234 
Cadherin-11  osteoblasts, fibroblasts214 9550 25 357 13061 
Endoglyx-1  endothelial100 125 11052 -279 12651 
Seprase  stroma215, 216 4728 47 86 12055 
Zac1  chondrocytes217, myocytes218 6288 18 607 11939 
Follistatin-like 1  pre-adipocytes121, myocytes219, 
220 
8649 65 112 11845 
Endothelial cell-specific molecule 
1  
adipocytes102 8557 48 193 11798 
PTPRD pre-B cells213 4355 34 141 11403 
Glycoprotein m6a neurons221 134 10273 -194 11389 
PDGFRb  stroma88, pericytes222 8909 47 218 11203 
Glia-derived nexin skeletal muscle223 17607 164 93 11042 
kit ligand  stroma, osteoblasts224 11822 72 161 10807 
Procollagen VI, α1  muscle, adipocytes, 
chondrocytes 
4851 25 211 10624 
Kininogen 1 - 4754 8 719 10614 
Leptin receptor  stroma225 8267 248 30 10543 
Rap guanine nucleotide exchange 
factor (GEF) 5 
- 97 1798 -16 10426 
Osteoglycin osteoblasts, vSMCs 4927 12 516 9754 
Glutathione peroxidase 3  plasma, adipose tissue 9428 109 86 9547 
ACAM adipocytes103 1740 75 23 9466 
Mannose receptor, C type 1 myoblasts226 152 10963 -108 9069 
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Fatty acid binding protein 4, 
adipocyte 
endothelium227 1363 35686 -35 8988 
Stabilin 2  endothelium228, 229 212 11911 -101 8773 
Anthrax toxin receptor 1 endothelium230 5488 194 27 8689 
FAT tumor suppressor homolog 1  vSMCs231 4048 42 99 8600 
VEGFC macrophages232, osteoclasts 4295 48 86 8513 
Secreted frizzled-related protein 
4  
- 9536 80 118 8495 
Lysyl oxidase-like 1 vSMCs233 4694 9 481 8482 
Aquaporin 1 erythrocytes, endothelium234 173 6266 -33 8271 
 
Tab. S3: Overview of RNA quantity and quality from FAC sorted sub-populations of IL7KI GFP+/- stromal cells 
Sample # mice CD45-VCAM-1+GFP+PECAM-1- CD45-VCAM-1+GFP-PECAM-1- 
RNA content [ng] RIN RNA content [ng] RIN 
1 1 107 N/A 139 N/A 
2 2 212 N/A 163 N/A 
3 1 146 N/A 119 N/A 
 
Tab. S4: Significantly differentially expressed genes in GFP+PECAM-1- BMSCs in comparison with GFP-PECAM-1- 
control cells ranked by HPCDA score Table denotes gene (names) and corresponding originating); multiple 
appearances of a gene indicate more than one positive probe set; Sig S: mean corrected signal intensity of 
GFP+PECAM- chip samples; Sig E: mean corrected signal intensity of GFP-PECAM- chip samples; FC: fold change; 
data is derived from 3 different experiments 
Gene Gene name Sig S Sig E FC HPCDA-
Score 
S100a8 S100 calcium binding protein A8 (calgranulin A) 24021.3 49716.6 -2.30 2630.49 
S100a9 S100 calcium binding protein A9 (calgranulin B) 17320.4 43289.5 -2.38 2619.40 
Ngp neutrophilic granule protein 4852.5 21509 -4.00 2487.33 
Camp cathelicidin antimicrobial peptide 4329.1 21460.6 -5.10 2390.79 
Mpo myeloperoxidase 2264.9 13826.5 -8.00 1749.58 
Lyz1 lysozyme 823.9 10737 -4.29 1605.34 
Hmgn2 high mobility group nucleosomal binding 
domain 2 
3571.1 14169.5 -4.21 1512.86 
Chi3l3 chitinase 3-like 3 2547.05 15175.4 -5.76 1504.80 
Srgn serglycin 1869.25 9582.5 -5.46 1468.63 
Lyz1 lysozyme 3119.8 14065.3 -4.29 1427.03 
Prtn3 proteinase 3 1526.25 9309.2 -8.00 1420.97 
Rps6 ribosomal protein S6  7522.3 11809.6 -1.62 1367.89 
Rps6 ribosomal protein S6 6279.85 10238.5 -1.62 1323.26 
Chi3l3 
/Chi3l4 
chitinase 3-like 3 / 4 1729.9 12314.2 -6.73 1269.91 
Lyz2 lysozyme 2580.2 11881.5 -4.84 1250.85 
Tacc3 transforming, acidic coiled-coil containing 
protein 3 
51.35 192.3 -3.86 1077.03 
Tkt transketolase 2981.05 10548.5 -3.93 1069.43 
Ly6c1 /Ly6c2 lymphocyte antigen 6 complex, locus C1/2 1129.25 6650.15 -6.61 963.09 
Lair1 leukocyte-associated Ig-like receptor 1 54.5 248.75 -3.61 959.99 
Ear1 eosinophil-associated, ribonuclease A family, 
member 1 
510.9 4012.25 -
24.25 
953.26 
Ube2c ubiquitin-conjugating enzyme E2C 195.15 601.4 -3.48 942.50 
Arhgap30 Rho GTPase activating protein 30 48.95 302.75 -5.66 929.91 
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Ctsg cathepsin G 810.9 5078.65 -7.73 925.39 
Prrx1 paired related homeobox 1 462.7 218.35 2.18 919.41 
Svip Small VCP Interacting Protein 70.15 244.4 -3.67 878.96 
Ear2 eosinophil-associated, ribonuclease A family, 
member 2  
377.05 2868.9 -
11.92 
835.05 
Dmp1 dentin matrix protein 1 92.55 291.75 -3.08 831.47 
Ear1 eosinophil-associated, ribonuclease A family, 
member 1 
106.55 1572.05 -8.57 828.58 
Mpeg1 macrophage expressed gene 1 208.3 500.55 -2.69 822.47 
Far2 male sterility domain containing 1 42.9 180.3 -3.93 819.38 
Lcn2 lipocalin 2 1593.15 7781.5 -4.59 818.72 
Serpinb1a serine (or cysteine) peptidase inhibitor, clade B, 
member 1a 
475.25 4989.25 -9.51 813.24 
Tuba4a tubulin, alpha 4A 917.75 5890.2 -6.96 813.04 
Arhgap9 Rho GTPase activating protein 9 83.55 230.15 -2.42 804.46 
Prg2 proteoglycan 2, bone marrow 204.45 2188.5 -
15.19 
797.19 
Gpx1 glutathione peroxidase 1 2294.95 6813.3 -3.08 792.71 
Nup210 nucleoporin 210 73.05 336.8 -4.21 775.32 
Tcfec transcription factor EC 8.2 262.1 -
34.90 
768.19 
Hmgb2 high mobility group box 2 980.25 4753.65 -4.59 760.10 
Strbp spermatid perinuclear RNA binding protein 32.05 117.4 -2.73 754.51 
Ms4a3 membrane-spanning 4-domains, subfamily A, 
member 3 
457.45 3460.75 -9.85 753.59 
Dkc1 dyskeratosis congenita 1, dyskerin homolog 
(human) 
246.3 514.7 -1.93 748.23 
B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 6.5 115 -8.00 736.02 
Hnrnpf heterogeneous nuclear ribonucleoprotein F  1249.15 2306.9 -1.65 731.70 
Msra methionine sulfoxide reductase A 221.75 385.1 -2.14 729.93 
 
 
Fig. S1: Annexin A2 receptor is expressed in the B lymphocyte lineage in the spleen    A: Histological slides from 
C57Bl/6 femora were incubated with antibodies against Annexin A2 receptor (ANXA2R, green), Thy1 (red), CD44 
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(blue); B: ANXA2R (green), B220 (red), IgM/IgD/kappa + lambda light chain (light grey); white circle: rare 
phenotype of B220-ANXA2Rhi(IgM-IgD-k/l-) cell; scale: 50 µm 
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